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Abstract 
Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a multifunctional protease that 
degrades proteins during cell migration, and influences cell survival. Both the protein 
localization and signal transduction capabilities of MT1-MMP depend on its cytoplasmic 
domain (CD), indicative of a diverse regulatory function. The effects of CD mutations on cell 
migration and survival were examined by ectopically expressing MT1-MMP variants in 
MCF-7 cells. CD alteration by substitution or deletion did not abolish the migration-
promoting effects of MT1-MMP, but did decrease cell survival and increase apoptosis. 
Expression of CD-altered MT1-MMP resulted in a protrusive cell morphology in 3D culture 
that was lost upon serum starvation. MT1-MMP expression in a chicken embryo tumour 
model resulted in vascularization of MCF-7 tumours; a phenotype that was partially 
maintained following expression of MT1-MMP CD variants. These results suggest that the 
CD regulates MT1-MMP localization in a manner required for cell survival, but is 
dispensable for cell migration.  
  
Keywords 
Matrix metalloproteinases, MT1-MMP, cytoplasmic domain, extracellular matrix, cell 
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Chapter 1  
1 Introduction 
1.1 The Extracellular Matrix 
The functions of cells in tissues are influenced by the composition and structure of the 
extracellular matrix (ECM), a dynamic physical and chemical network of secreted 
proteins and macromolecules that includes collagens, laminins, fibronectins and 
proteoglycans. Interacting reciprocally, epithelial and stromal cells locally produce and 
secrete ECM molecules, which assemble and in turn regulate the shape, growth and 
function of the embedded cells (Kim, Turnbull, & Guimond, 2011). Importantly, the 
composition of proteins within the ECM can differ both temporally and spatially, 
allowing for cell-ECM interactions to be adaptable and unique during specific cellular 
and developmental processes and in tissue structures (Daley, Peters, & Larsen, 2007). 
The most basic function that the ECM provides is a physical scaffold on which cells 
grow, organize, and adhere to one another, thereby allowing for the maintenance of tissue 
integrity. However, current understanding of the role and function of the ECM has 
expanded, and it is now recognized that the ECM has an important role in regulating and 
directing cell behaviour (Anilkumar et al., 2005).  
As the substrate upon which cells grow, the ECM acts to inhibit cell movement by 
functioning as a physical barrier. Indeed, invasive cell types must adopt distinct 
morphologies to circumvent the barrier of the ECM (Sahai & Marshall, 2003), and ECM 
degradation is an essential step in the progression of epithelial metastases (Rowe & 
Weiss, 2009). However, the proteins of the ECM also serve as the track on which cells 
migrate, as they provide the substrate to which focal adhesions form during the 
progression of cell migration (Lu, Weaver, & Werb, 2012). In this way, the ECM 
provides dynamic directional cues to migrating cells as its protein composition changes to 
be more or less permissive to the corresponding cell surface integrins. These mechanisms 
allow the ECM to both positively and negatively regulate the initiation and continuation 
of cell movement.  
2 
 
As an indirect effector of cell behaviour the ECM can serve as a reservoir of secreted 
signaling molecules, as charged components of the network attract and sequester ligands 
away from the cell surface. Thus, the ECM both limits the diffusive range of molecules 
and temporally influences the activation of cell signaling, as these sequestered factors can 
be liberated upon the cleavage of ECM components (Rahman et al., 2005). This retention 
is particularly influential during development, where molecules such as fibroblast growth 
factors (FGFs) and vascular endothelial growth factors (VEGFs) are sequestered and 
released along gradients that develop from secretory cells. While ECM proteins are 
passively involved in this process, they can also directly influence signaling, such as the 
specific requirement of the ECM molecule heparin to present the FGF ligand to its 
receptor on the cell surface (Hynes, 2009). By modulating cell signaling, the ECM serves 
important roles distinct from its physical properties. 
Structurally, the ECM is subdivided into two distinct layers or forms: the interstitial 
matrix and the basement membrane. The interstitial matrix is comprised mainly of 
fibrous collagens and proteoglycans, and is found mostly in connective tissue. The 
basement membrane, which directly underlies epithelia, is a dense barrier made of 
primarily collagen IV and serves to support and inhibit the movement of cells (Pöschl et 
al., 2004). Structurally, the pattern of collagen crosslinks within the basement membrane 
results in a thickness of 100-300 nm and creates holes between fibers of 50 nm in size, far 
smaller than the permissive size of 2 µm required for cell migration (Rowe & Weiss, 
2009). For cells to breach this basement membrane it must be remodeled, and indeed, the 
ECM differs structurally and compositionally in response to changes in normal 
physiology or pathology.  
This plasticity of the ECM is evidenced by the many processes which underlie 
organismal development, including the wide-scale cell movement observed during 
gastrulation, where epithelial cells degrade and transverse the basement membrane during 
epithelial to mesenchymal transition (Rowe & Weiss, 2009). However, these same 
mechanisms are co-opted during pathologies such as fibrosis and cancer metastasis, 
where the degradation or composition of the ECM is dysregulated to result in malignant 
cell behaviour (Lu et al., 2011). For example, ECM modifications associated with breast 
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cancer involve remodeling that not only degrades components of the ECM, but also 
paradoxically results in the remaining ECM to become stiffer, a quality recognized by 
cells which can induce and increase their migration (Gilkes, Semenza, & Wirtz, 2014). In 
addition to altered mechanics, as the ECM experiences degradation, porosity increases 
and facilitates the amoeboid invasion of epithelial cells through it (Wolf et al., 2003). 
Thus the ECM has a great influence on the integrity of tissues and the regulation of the 
cells within by either promoting or restricting cell movement by both physical and 
chemical means.  
1.2 The Matrix Metalloproteinases 
In order to regulate the diverse functions of the ECM and maintain homeostasis, 
constituent proteins must be subject to renewal or degradation. A number of enzymes 
function to degrade ECM proteins, including a disintegrase and metalloproteinases 
(ADAMs), numerous serine proteases, and matrix metalloproteinases (MMPs), which all 
proteolytically cleave the polymers of the ECM to change its composition (Lu et al., 
2011; Seals & Courtneidge, 2003). Of these, the most diverse and widely-studied are the 
MMPs, which comprise 24 identified members in humans that collectively are able to 
degrade all known protein components of the ECM (Löffek, Schilling, & Franzke, 2011). 
MMPs are distinguished by the conserved histidine motif HEXXHXXGXX(H/D) within 
the catalytic domain, which chelates the zinc atom necessary for catalysis (Stocker & 
Bode, 1995).  
MMPs are described and classified by two independent attributes: substrate specificity 
and cellular location. The classes of collagenases, gelatinases, stromelysins and 
matrilysins are distinguished by differences in the catalytic and hemopexin domains 
which impart specificities to these groups of ECM substrates. However, MMPs are more 
commonly classified based on their functional location, as 18 are secreted and function as 
soluble mediators of degradation, while the six membrane-type (MT) MMPs function at 
the cell surface (Bourboulia & Stetler-Stevenson, 2010). All MMPs share a basic domain 
structure which includes an N-terminal signal sequence, an autoinhibitory pro-peptide, 
and a catalytic domain. With the exception of MMP-7 and MMP-21, all MMPs also 
possess a hemopexin-like structural domain that mediates protein binding. Membrane-
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type MMPs 1, 2, 3 and 5 also contain a single-pass transmembrane domain and 
cytoplasmic domain, while MT4-MMP and MT6-MMP are membrane localized by a GPI 
anchor (Cauwe, Van den Steen, & Opdenakker, 2007). 
Due to their potency and the importance that ECM composition has on cell function, the 
activity of MMPs is tightly regulated post-translationally by both latency and the activity 
of the endogenous MMP inhibitor protein family, the tissue inhibitors of 
metalloproteinases (TIMPs). Nascent MMPs are zymogens, as their N-terminal pro-
domain functions to physically bind and block the active site within the catalytic domain. 
The pro-domain is proteolytically cleaved and removed to allow for enzymatic activity. 
The manner in which this activation occurs differs depending on the structural 
classification of MMP, as membrane-type MMPs have the pro-domain cleaved in the 
secretory pathway by pro-protein convertases, primarily furin, while secreted MMPs are 
released to the extracellular milieu as zymogens and become activated extracellularly by 
other proteases, such as MT-MMPs already present at the cell surface (Remacle et al., 
2006). As MT-MMPs are membrane-inserted in an active form, they are immediately in a 
position to be inhibited by TIMP family members, some of which are ubiquitously 
expressed. The mammalian TIMP family consists of TIMP-1, -2, -3 and -4, all of which 
are secreted and function in the extracellular space. Each TIMP family member is capable 
of inhibiting every MMP, though with varying efficiencies. TIMP proteins contain two 
functional domains, an N-terminal MMP-inhibitory domain and a C-terminal protein 
binding domain which is capable of binding a number of cell surface proteins (Moore & 
Crocker, 2012). While the primary identified role of TIMPs is to inhibit MMPs, they also 
have functions independent of this activity, including the regulation of cell survival 
(Stetler-Stevenson, 2008). Additionally, TIMPs can positively regulate the activation of 
MMPs, as will be described below (Itoh et al., 2001).  
As many MMPs have overlapping specificities to substrates, individual protease function 
is often dictated by their differential expression patterns (Sternlicht & Werb, 2001). This 
differential expression is accomplished as their transcription is controlled by a complex 
orchestration of cytokines, including interleukins, growth factors, and tumour necrosis 
factor-α, which also restrict their expression in adult tissues to very low levels (Moore & 
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Crocker, 2012; Sternlicht & Werb, 2001). Additionally, depending on the time, location, 
or the expression of TIMP proteins, certain MMPs may be more or less capable of 
catalysis. As such, identifying the specific, divergent functions of individual MMPs is 
necessary in order to understand their many roles in the regulation of ECM degradation 
and cell behaviour.   
1.3 Membrane-type 1 Matrix Metalloproteinase 
The prototypical and most extensively studied member of the membrane-type MMPs is 
membrane-type 1 MMP (MT1-MMP). While its expression is heavily restricted in adult 
tissues, MT1-MMP is essential during embryonic development, as MT1-MMP knockout 
mice die shortly after birth (Holmbeck et al., 1999). MT1-MMP is classified as a 
collagenase, and its principle ECM substrates include collagen types I, II and III, 
fibronectin, and laminins-1 and -5 (Ueda et al., 2003). However, MT1-MMP is also 
capable of cleaving non-ECM proteins, including cell surface receptors such as CD44 
and E-cadherin. This diverse repertoire of substrates means that MT1-MMP can greatly 
influence cell-ECM interactions and corresponding cell behaviour.   
In addition to cleaving ECM protein substrates and cell surface molecules, MT1-MMP is 
a principal activator of the gelatinase MMP-2. As MMP-2 is one of the few enzymes 
capable of cleaving type-IV collagen, this effectively makes MT1-MMP activity capable 
of mediating the degradation of all major types of collagen, poising it as a potent 
organizer of invasion (Zeng, Cohen, & Guillem, 1999). Importantly, the mechanism by 
which MT1-MMP activates MMP-2 is well described, and highlights the importance of 
the domain structures of MMP-2, MT1-MMP, and its inhibitor, TIMP-2. In the 
extracellular space, the N-terminal of TIMPs typically bind MMPs at the catalytic site to 
inhibit their enzymatic activity. However, since access to the catalytic domain of pro-
MMP-2 is sterically blocked due to the binding of its pro-domain, the C-terminal of 
TIMP-2 alternatively binds pro-MMP-2 at its hemopexin-like domain. At the cell surface, 
the exposed, inhibitory N-terminal of TIMP-2, now attached to pro-MMP-2 at its C-
terminus, is free to bind and inhibit an MT1-MMP protein at its catalytic site. This 
trimeric association positions pro-MMP-2 to be cleaved by an adjacent, uninhibited MT1-
MMP protein, and the active MMP-2 is subsequently released into the extracellular space 
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(Itoh et al., 2001). While MT1-MMP can activate MMP-2 without the presence of TIMP-
2, the paradox of the MMP-inhibiting TIMP-2 protein enhancing the activation of its 
substrate suggests that the regulation of ECM remodeling proteins is more complex than 
originally thought.  
Importantly, MT1-MMP has recently been recognized to have both proteolytic and non-
proteolytic functions which result in the enhancement of cell motility. Indeed, while 
MT1-MMP plays an integral role during development, especially throughout bone 
maturation (Holmbeck et al., 1999), its dysregulation promotes metastasis in many types 
of cancer. MT1-MMP has been found to promote or exacerbate five of the six defined 
“hallmarks of cancer”, which include proliferation independent of growth signals, 
insensitivity to growth reduction signals, angiogenesis, tissue invasion, and evasion of 
apoptosis. Only the heightened replicative ability of cancer cells remains unrelated to the 
functions of MT1-MMP (Maquoi et al., 2012). The duality of its essential function during 
development and its malignancy-promotion during cancer has raised intense interest in 
the research community to understand how cell motility and survival are regulated by 
MT1-MMP.  
1.4 MT1-MMP and cell motility 
MT1-MMP is frequently described as being pro-invasive and pro-migratory, and its 
increased expression is associated with invasive cell types including immune cells and 
cancers (Figueira et al., 2009). The process of cell migration has been extensively 
described, and is initiated by the binding of chemoattractants or other pro-migratory 
ligands to their cell surface receptors. This induces a cell signaling cascade which 
influences, among many things, gene transcription and cytoskeletal dynamics. Actin 
polymerizes at the leading edge of the cell, due to the local activity of multiple actin 
binding proteins including WASP and ARP2/3. This polymerization pushes membrane 
extensions from the cell surface, called filopodia or lamellipodia, which contact the ECM 
and bind to it using specific integrins to form focal adhesions. Actin and myosin can 
contract to move the cell body forward, while the trailing edge of cells detaches from the 
ECM (Friedl & Wolf, 2003).  
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An additional step during cell migration occurs if cells must move through the barrier of 
the ECM, as it must be degraded. It is well-documented that MT1-MMP localizes to the 
leading edge of the cells, where it is presumed to promote matrix cleavage directly at the 
cell-ECM interphase allowing for cell migration through it (Mori et al., 2002). Indeed, 
the proteolytic activity of MT1-MMP is frequently implicated in processes wherein MT1-
MMP promotes both migration and invasion. The cleavage of laminin-5 specifically by 
MT1-MMP in a number of cell types has been shown to trigger the migration of cells 
(Koshikawa et al., 2000), while a soluble mutant form of MT1-MMP is incapable of 
promoting cell migration (Hotary et al., 2000), suggesting that membrane localized 
degradation is crucial for this function. In addition, CD44, a hyaluronan receptor, is 
notable for its involvement in cell migration and is also a substrate of MT1-MMP (Ueda 
et al., 2003). When the two proteins co-localize during their recruitment to the 
lamellipodia of migrating cells, the shedding of CD44 by MT1-MMP-mediated cleavage 
promotes the migration of cells over ECM. (Itoh, 2006; Koshikawa et al., 2000). A 
proposed mechanism for the induction of cell migration suggests that this shedding 
disrupts the weak initial interactions between the substrate and CD44, allowing for 
stronger integrin interactions to form in their place (Cauwe et al., 2007).  
However, a well-defined mechanism for MT1-MMP-mediated cell migration remains 
elusive, as a number of reports show that the expression of constitutively inactive forms 
of MT1-MMP still result in increased cell migration (Bonnans, Chou, & Werb, 2008; 
Hara et al., 2011). These reports posit that MT1-MMP may influence the ability of cells 
to adaptively use amoeboid-like migration mechanisms, where cells passively move 
through existing spaces in the ECM rather than rely on degradation. This discrepancy is 
supported by the recent focus on the non-proteolytic mechanism of MT1-MMP-mediated 
cell migration, as a transducer of the extracellular signal-regulated protein kinase (ERK) 
cascade. The activity of ERK, a kinase which influences the transcription of a number of 
genes, results the promotion of cell migration. Many reports have shown that the binding 
of TIMP-2 to MT1-MMP induces the activation of ERK in a dose and time-dependent 
manner to result in increased cell migration (D’Alessio et al., 2008; Sounni et al., 2010). 
However, the specific requirements for this signaling mechanism remain poorly 
understood, as some reports show that MT1-MMP must be in its active form to transduce 
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this signal, while others maintain that ERK activation occurs independently of MT1-
MMP proteolytic activity.  
In contrast to cell migration upon ECM protein substrates, MT1-MMP is directly 
involved in breaching the dense basement membrane of the ECM during cell invasion. 
Specific degradative cellular structures rich in MT1-MMP form in invasive cells. While 
structurally similar, these are called podosomes in normal cells and invadopodia if 
formed in cancerous cells (Om Alblazi & Siar, 2015). These actin-rich cellular 
protrusions form on the basal side of cells and actively recruit MT1-MMP, which 
functions as the principle proteolytic component to cleave ECM and activate MMP-2, 
which can degrade the underlying type-IV collagen (Poincloux, Lizárraga, & Chavrier, 
2009). The formation of invadopodia has been described as an orchestrated, step-wise 
process where a membrane protrusion is created by actin polymerization, followed by 
MT1-MMP being shuttled to the distal end (Artym, 2006). Importantly, this formation 
relies on hundreds of individual proteins that regulate the initiation and regulation of 
actin dynamics, vesicular transport, and cellular adhesion (Alblazi & Siar, 2015). While 
the basal machinery of invadopodia still functions in the absence of MT1-MMP, the 
resulting structures are non-functional and do not degrade substrate (Buccione et al., 
2009; Itoh et al., 2006). 
While invadopodia and podosomes are distinct invasive cellular processes, comparisons 
can be drawn between the recruitment of MT1-MMP to actin structures of lamellopodia 
during cell migration, and suggests that MT1-MMP cell surface localization and 
cytoskeletal arrangements function together in multiple facets of cell motility. However, 
the role of MT1-MMP in promoting cell invasion through degradative structure is much 
more defined and understood, while the mechanisms by which it initiates and continues 
cell migration are less so (Artym, 2006). Indeed, while it is accepted that MT1-MMP 
promotes cell migration, the specific contributions of each of the diverse activities of 
MT1-MMP including catalytic activity, binding partners or localization are far from 
understood.  
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1.5 MT1-MMP and cell survival 
The pro-invasive cell phenotype conferred by MT1-MMP extends beyond increased 
migration and ECM degradation, and includes its ability to promote cell survival through 
multiple mechanisms. Although MT1-MMP has long been described solely as a protease, 
a number of these non-proteolytic functions of MT1-MMP that impact cell behaviour are 
beginning to emerge (Hara et al., 2011; Pahwa, Stawikowski, & Fields, 2014).   
Invading cells encounter new extracellular environments as they move from their point of 
origin, and for invasive epithelial cells which have breached the basement membrane this 
is typically the type-I collagen-rich interstitial matrix. Collagen-I is resistant to cleavage 
but to a few enzymes (including MT1-MMP), limits cell proliferation and induces 
apoptosis through BIK upregulation due to Src kinase activity (Assent et al., 2015). When 
cells expressing MT1-MMP were seeded into a collagen-1 matrix, they were able to 
evade collagen-induced apoptosis through an MT1-MMP-dependent mechanism (Maquoi 
et al., 2012). Yet this protection that MT1-MMP provides to cells against apoptosis is not 
necessarily dependent on proteolysis, as independent reports have shown that TIMP-2 
binding to MT1-MMP results in the activation of Akt. The PI3-K/Akt cell signaling 
pathway is known for its involvement in the regulation of cell survival and proliferation 
(Grandage et al., 2005), and MT1-MMP-mediated Akt activation, which is responsive to 
the dosage and time of TIMP-2 exposure, results in the protection of cells against serum 
starvation-induced apoptosis. Yet TIMP-2, as an inhibitor to MT1-MMP, decreased cells’ 
resistance to collagen-I-induced apoptosis, suggesting that this regulation of cell survival 
is adaptive and dependent on environmental cues (Valacca, Tassone, & Mignatti, 2015).   
MT1-MMP’s role in cell survival can also be mediated through its ability to alter cellular 
metabolism by increasing glycolysis. Elevated glycolysis, even in the presence of 
adequate oxygen, is termed the Warburg Effect. Activation of the Warburg effect by 
MT1-MMP is accomplished in part by the increased transcriptional activity of HIF-1α 
(hypoxia-inducing factor), regardless of oxygen conditions. This phenomenon involves 
multiple protein interactions and begins during processing and activation of MT1-MMP 
in the Golgi. At this cellular location, the cytoplasmic domain of MT1-MMP interacts 
with the adaptor protein Mint3, resulting in the recruitment and inhibition of Factor-
10 
 
Inhibiting HIF-1α (FIH). HIF-1α – a transcription factor which mediates cells’ responses 
to hypoxia – is stabilized by the removal of this negative regulation and can alter 
expression of multiple genes, leading to elevated expression of glycolytic enzymes. 
Importantly, FIH typically only experiences negative regulation during hypoxic 
conditions, ensuring that a glycolytic shift in metabolism only occurs during times of low 
oxygen. MT1-MMP-mediated induction of the Warburg effect allows for an increase in 
substrate-level phosphorylation even in normoxia (Sakamoto & Seiki, 2010). This 
process has been found to be a key metabolic event in both macrophages and cancer cells, 
and increases cell survival. Specifically in macrophages, cells which had MT1-MMP 
expression knocked down exhibited less glycolysis and an impairment of cell migration 
(Sakamoto, Niiya, & Seiki, 2011), illustrating how the diverse functions of MT1-MMP 
combine to influence cell behaviour.  
1.6 The cytoplasmic domain of MT1-MMP 
Recent focus has turned to the cytoplasmic domain of MT1-MMP and its influence on 
protein function. Interestingly, this 20 amino acid sequence has been implicated in many 
of the diverse proteolytic and non-proteolytic functions of MT1-MMP, both directly and 
indirectly. 
The cytoplasmic domain is responsible for the membrane localization and internalization 
dynamics of MT1-MMP at the cell surface. The localization of MT1-MMP to the leading 
edge of migrating cells is disrupted upon cytoplasmic domain deletion (Lehti et al., 
2000), as is its inclusion in lipid raft membrane compartments, distinct sections of the cell 
membrane concentrated with signaling molecules and cell surface receptors (Rozanov et 
al., 2003). In addition, both the clathrin- and caveolin-mediated mechanisms for MT1-
MMP internalization are impaired when mutation are introduced within the cytoplasmic 
domain. During clathrin endocytosis, the LLY573 sequence within the cytoplasmic 
domain binds to the µ2 subunit of AP-2 to facilitate this internalization of MT1-MMP. 
The importance of this sequence for MT1-MMP internalization was revealed when 
alanine substitutions within LLY573 resulted in lack of binding of MT1-MMP to AP-2 
and co-localization with clathrin, ultimately leading to marked decreases in MT1-MMP 
internalization (Uekita et al., 2001). The cytoplasmic domain is also necessary for the 
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localization of MT1-MMP to caveolae, special areas of the cell membrane which 
invaginate, as deletion of this domain abrogated the interaction of MT1-MMP with 
phosphorylated caveolin-1 at the cell surface (Labrecque et al., 2004). In addition, the 
recycling of MT1-MMP from internalized vesicles back to the cell surface has been 
found to depend on the cytoplasmic domain. The DKV582 sequence in the cytoplasmic 
domain is necessary for regular re-insertion of internalized MT1-MMP-positive vesicles 
to the cell membrane (Wang et al., 2004).  
The cytoplasmic domain also has a putative role in the activation of MT1-MMP during 
protein maturation, as it is a binding site for the adaptor protein Golgi Reassembly 
Stacking Protein 55 (GRASP55). GRASP55 associates with the Golgi complex and is 
involved in maintaining the structure of cisternae and the intracellular transport of both 
secreted and membrane proteins. In addition, GRASP55 has been identified as a binding 
partner of both MT1-MMP and furin, the pro-protein convertase responsible for MT1-
MMP protein activation. The LLY573 sequence within the cytoplasmic domain of MT1-
MMP was identified as essential to mediate the binding of GRASP55 to MT1-MMP in 
MT1-MMP and Furin-positive locations in the Golgi, illustrating a role for the 
cytoplasmic domain in proper MT1-MMP maturation (Roghi et al., 2010). Once at the 
cell surface, the cytoplasmic domain has a further role in the MT1-MMP-mediated 
activation of pro-MMP-2, as the association of the trimeric pro-MMP-2, TIMP-2 and 
MT1-MMP complex with a second MT1-MMP protein fails to occur (Rozanov et al., 
2001). 
As previously described, the cytoplasmic domain of MT1-MMP is essential to MT1-
MMP-mediated activation of the Warburg effect by binding Mint3 to sequester Factor-
Inhibiting HIF-1α. Experiments which employ a mutant of MT1-MMP without a 
cytoplasmic domain show that the increase in glucose metabolism shown in MT1-MMP-
expressing cells is abolished when the cytoplasmic domain is deleted (Sakamoto & Seiki, 
2009). Similarly, other signaling events that are mediated by MT1-MMP, including the 
initiation of the ERK and Akt activation pathways, require the cytoplasmic domain 
(D’Alessio et al., 2008; Gingras et al., 2001). While the specific role that the cytoplasmic 
domain plays during these signaling events is not understood, both its phosphorylation, 
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which is accomplished by Src (Nyalendo et al., 2007) or PKC (Williams & Coppolino, 
2011), or its involvement in the binding to other signaling proteins (Pratt et al., 2015; 
Uekita et al., 2004) have been implicated.  
In these diverse ways, this short cytoplasmic domain has disproportionate regulatory 
influence over the diverse functions of MT1-MMP. Further elucidating the role of the 
cytoplasmic domain on MT1-MMP functions presents as a promising opportunity to 
examine the proteolytic and non-proteolytic contributions of MT1-MMP to cell invasion, 
migration and survival. 
1.7 Hypothesis and objectives 
MT1-MMP has multiple functions within cells that impart a pro-migratory phenotype 
which contributes to developmental and pathological processes. Importantly, these 
functions are both proteolytic and non-proteolytic in nature, suggesting that the 
mechanisms which regulate MT1-MMP are diverse. The recurring role of the 
cytoplasmic domain in MT1-MMP processes makes it an attractive target of examination 
to understand the regulation of the invasion and survival-promoting effects of MT1-
MMP.   
I hypothesize that the cytoplasmic domain of MT1-MMP is necessary for its 
promotion of cell migration and survival in MCF-7 breast cancer cells. 
Using MT1-MMP-deficient MCF-7 human breast cancer cells, and three MT1-MMP 
expression constructs possessing different cytoplasmic domain mutations, a series of 
overexpression experiments were performed to assess changes in MT1-MMP function 
and cell behaviour. Expression of MT1-MMP with altered cytoplasmic domains in MCF-
7 cells will help build a comprehensive model in which the role of its cytoplasmic 
domain in cell migration and survival is more clearly defined.    
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Chapter 2  
2 Materials and Methods 
2.1 Acquisition of MT1-MMP cytoplasmic domain mutant 
constructs 
Experimental cDNA constructs of human MT1-MMP with altered cytoplasmic domains 
were generated using PCR. All constructs were generated by PhD candidate Mario 
Cepeda, Western University as follows: full length human MT1-MMP and MT2-MMP 
cDNA were purchased (Origene, SC116190 and SC118648) and subjected to primer-
directed mutagenesis to create two constructs. The cytoplasmic domain of MT1-MMP 
within the MT2CD MT1-MMP construct was replaced with the sequence for the MT2-
MMP cytoplasmic domain. A stop codon was introduced into the ∆CD MT1-MMP 
construct to generate a truncated MT1-MMP protein possessing a transmembrane domain 
but lacking its cytoplasmic domain. The wild-type human sequence of MT1-MMP is 
referred to as full-length (FL) MT1-MMP. The DNA sequences of these generated clones 
were confirmed at Robarts Research Institute (London, ON) and subsequently subcloned 
into the pcDNA 3.3 expression vector (Origene). The domain structure and amino acid 
sequences of the cytoplasmic domain of the protein products of each clone is illustrated 
in Figure 1. 
2.2 Cell culture conditions 
Human adenocarcinoma breast cancer cell lines MDA-MB-231 and MCF-7 were a gift of 
Dr. Lynne-Marie Postovit, University of Alberta. All cells were cultured in Dulbecco’s 
Modified Eagles (DMEM)/F-12 medium (Thermo Fisher) supplemented with 10% fetal 
bovine serum (FBS) and 1% streptomycin/penicillin and incubated at 37°C in a 
humidified incubator with 5% CO2. Serum-free conditions describe DMEM/F-12 media 
and 1% streptomycin/penicillin only. Cells were maintained below 80% confluency and 
passaged accordingly using 0.25% Trypsin-EDTA (Thermo Fisher). 
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Figure 1. Schematic representation of the human MT1-MMP protein domains and 
modifications made to cytoplasmic domain mutant constructs.  
Multiple functional domains are present in MT1-MMP, including an N-terminal signal 
sequence (SS); an auto-inhibitory pro-domain; a catalytic domain, which contains the 
zinc-dependent active site; a flexible hinge region; a hemopexin-like domain which 
modulates protein interactions; a transmembrane domain (TM); and a cytoplasmic 
domain 20 amino acids in length. The three experimental constructs of MT1-MMP differ 
only in the sequences of their cytoplasmic domains (CD), the amino acid sequences of 
which are shown. FL (full-length) MT1-MMP possesses the wild-type human MT1-
MMP cytoplasmic domain sequence, MT2CD MT1-MMP has the cytoplasmic domain 
sequence from MT2-MMP substituted, and ∆CD MT1-MMP contains a premature stop 
codon following Phe562 resulting in the termination of translation before the cytoplasmic 
domain. The site-for-site amino acid identity between the MT1-MMP and MT2-MMP 
cytoplasmic domains is indicated. 
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2.3 Transfection and generation of stable cell lines 
For transient transfection, MCF-7 and MDA-MB-231 cells were seeded at a density of 
5x105 cells/mL and incubated for 24 hours. Following incubation, cells were transfected 
with 2.5 µg of FL MT1-MMP, MT2CD MT1-MMP, ∆CD MT1-MMP or GFP cDNA (all 
in pcDNA 3.3 TOPO, Thermo Fisher) using Lipofectamine 2000 (Thermo Fisher) and 
OPTI-MEM reduced serum media (Thermo Fisher) as per manufacturers’ instructions. 
For experiments utilizing transient transfection, cells were incubated for 24 hours 
following transfection prior to further use.  
The pcDNA 3.3 vector used contained a neomycin mammalian selection marker. Stable 
MCF-7 cell lines, referred to as MT2CD MT1-MMPst and ∆CD MT1-MMPst, were 
generated by transfecting cells with each of the above constructs by the protocol outlined 
previously. Twenty four hours after transfection, these cells were seeded at 1:1000 
dilution in DMEM/F-12 media containing 1 mg/mL neomycin (G148, TekNova) and 
maintained under selection conditions for four weeks in order to remove non-resistant 
cells that had not experience genomic insertion of the plasmid. Individual colonies 
representing a homogenous population arising from a single transfected cell were 
identified, isolated, expanded and assayed for MT1-MMP expression using qPCR. The 
additional stable cell lines MT1-MMPst and MT1-MMPH (high) were generated 
previously by PhD candidate Mario Cepeda by an identical protocol.  
Parental MCF-7, and the stable cell lines MT1-MMPst, MT2CD MT1-MMPst and ∆CD 
MT1-MMPst were further subject to viral transfected with a cDNA encoding ZsGreen, a 
cytoplasmic localized fluorescent protein, to generate the respective stably expressing 
ZsGreen lines ZsMCF-7, ZsMT1-MMPst, ZsMT2CD MT1-MMPst and Zs∆CD MT1-
MMPst. This procedure was generously performed by personnel in the laboratory of Dr. 
Hon Leong, Western University. This protocol involved treating cells with a lentivirus 
containing ZsGreen in polybrene, a reagent which aids in viral transfection. One day post 
transfection cells were treated with puromycin (2 µL/mL), which was replenished for 
three days. Successful stable transfection was determined using fluorescence microscopy. 
These cell lines were used exclusively in the avian chicken embryo assay.  
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2.4 Antibodies and reagents 
For immunoblot analysis and immunofluorescence imaging, the following primary 
antibodies were used: rabbit anti-MT1-MMP (1:1000, AB6004, Millipore), mouse anti-
MT1-MMP (1:200, SC-377097, Santa Cruz), mouse anti-β-Actin (1:1000, C4, Santa 
Cruz), and rabbit anti-phospho-histone-3 (pH3; 1:5000, SC-8656-R, Santa Cruz). Both 
MT1-MMP antibodies recognize the extracellular hinge region of MT1-MMP, and 
therefore are effective at identifying cytoplasmic-domain mutant proteins. Goat anti-
mouse IgG (H+L) (Bio-Rad) and goat anti-rabbit IgG (H+L) (Thermo Fisher) HRP 
conjugates were used as secondary antibodies for immunoblot analysis (1:10 000). For 
immunofluorescence, rabbit anti-MT1-MMP (1:200) was used in combination with one 
of anti-rabbit-IgG-Alexa488 or Alexa594 (Thermo Fisher) as the secondary antibodies 
(1:400). The MMP inhibitory reagent BB-94 (Batimastat) was supplied by Santa Cruz 
Biotechnology, while the ECM analog substance Matrigel was purchased from BD 
Biosciences. 
2.5 Protein collection and immunoblot analysis 
Transiently or stably transfected cells, seeded at a density of 5 x 105 cells/mL, were 
washed twice in cold PBS (pH 7.2) and lysed using cell lysis buffer (150 mM NaCl, 1% 
NP-40, 0.5% NaDC, 0.1% SDS, 50 mM Tris pH 8.0) supplemented with protease and 
phosphatase inhibitors (Thermo Scientific). Lysates were shaken on ice for 20 minutes 
and homogenized using the Misonix Ultrasonic Liquid Processors XL-2000 Series 
sonicator. Protein content of cell lysate was determined using a Pierce BCA Protein 
Assay Kit (Thermo Fisher) and 15 µg aliquots were subject to SDS-PAGE. For analysis 
of MT1-MMP protein, 15% acrylamide gels were used, while for phospho-histone 3 
protein analysis, 10% acrylamide gels were used. Following electrophoresis, proteins 
were transferred to PVDF membranes. 
Blots were blocked using either 0.5% or 5% BSA in TBST, as directed by the primary 
antibody manufacturer, and probed using the appropriate primary antibodies. Incubation 
with primary antibodies occurred overnight at 4°C, and secondary antibodies for one hour 
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at room temperature. Blots were analyzed using QuantityOne software and Molecular 
Imager® ChemiDoc™ XRS System (BioRad). 
2.6 Immunoprecipitation 
Immunoprecipitation was performed using Protein A/G PLUS-Agarose 
immunoprecipitation reagent (Santa Cruz) as per manufacturer’s instructions, to detect 
MT1-MMP protein in the stable cell lines MT2CD MT1-MMPst and ∆CD MT1-MMPst. 
In brief, 2.5 million cells were seeded in a 60 mm cell culture dish (Corning) and 
incubated for 24 hours, lysed in lysis buffer, and homogenized using a 20G syringe. 
Lysates were cleared of non-specific binding proteins through incubation with a normal 
rabbit IgG (1 µg, Santa Cruz, SC-2027) and Protein A/G PLUS-Agarose (20 µL) by 
rotation for one hour at 4°C. Lysates were centrifuged, protein content of the supernatant 
was quantified using the Pierce BCA Protein Assay Kit (Thermo Fisher), and aliquots 
containing 250 µg of protein were incubated with 1 µg of either normal rabbit IgG or 
rabbit anti-MT1-MMP (Millipore) at 4°C overnight. Lysates were again centrifuged, the 
supernatant discarded, and the pellet washed and suspended in lysis buffer for use in 
SDS-PAGE. In order to avoid detection of the anti-MT1-MMP antibody on the final 
western blots, MT1-MMP in cell lysates was precipitated from lysates using rabbit anti-
MT1-MMP (Millipore) and the blots were probed using mouse anti-MT1-MMP (Santa 
Cruz) with goat anti-mouse IgG HRP secondary antibodies.   
2.7 Gelatin zymography 
In order to assess the in vitro activation of pro-MMP-2 and examine the levels of MMP-2 
protein isoforms in the media of transfected MCF-7 cells, gelatin zymography was 
performed as previously described (Toth & Fridman, 2013). As MCF-7 cells express very 
low levels of MMP-2 and TIMP-2 (Figueira et al., 2009), media was collected from 
MCF-7 cells transfected with MMP-2 or TIMP-2 cDNA. This conditioned media (CM), 
containing high levels of these secreted proteins, was used at a dilution of 30 μL pro-
MMP-2 CM/mL incubation media or 10 μL TIMP-2 CM/mL incubation media to the 
incubation media of cells transfected with the MT1-MMP constructs. Conditioned media 
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was a gift of Mario Cepeda, Western University (Cepeda, 2012). All conditioned and 
incubation media lacked serum supplementation.  
In brief, for zymography, 1.5 x 105 cells/mL were seeded in a 12-well culture dish 
(Corning) and transfected with GFP, FL MT1-MMP, MT2CD MT1-MMP or ∆CD MT1-
MMP cDNA. Twenty four hours post-transfection, cells were incubated for 12 hours in 
serum-free media supplemented with the conditioned media containing pro-MMP-2, 
TIMP-2, both, or pro-MMP-2 with 20 µM BB-94. Following incubation, media was 
collected from transfected cells and 15 µL aliquots were subject to SDS-PAGE using 
10% polyacrylamide gels containing 0.1% porcine gelatin (Sigma, G2500). Gels were 
then washed in protein renaturing buffer (2.5% Triton X-100), and incubated for two 
days at 37°C in a developing buffer (0.005 M CaCl2 in Tris buffered saline, pH 7.5) to 
allow the renatured MMPs to cleave the embedded gelatin. The gelatin was stained with a 
0.5% Coomassie Brilliant Blue (BioRad) solution and progressively rinsed with a 
destaining buffer (50% methanol, 10% acetic acid) to reveal clear bands within the 
stained gel corresponding to the location of active MMPs. Gels were imaged using 
QuantityOne software and Molecular Imager® ChemiDoc™ XRS System (BioRad).  
2.8 RNA extraction and qPCR 
To verify the overexpression of MT1-MMP in prospective stable MT2CD MT1-MMP 
and ∆CD MT1-MMP cell lines, mRNA was extracted using the RNAeasy mini kit 
(Qiagen) following the manufacturer’s instructions. 1 μg of RNA was used to synthesize 
complementary DNA (cDNA) using qScript cDNA SuperMix (Quanta Biosciences). 
cDNA was then used for qPCR analysis to examine the levels of MT1-MMP and 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), used as an internal control. qPCR 
was performed using SensiFAST SYBR No-ROX kit (FroggaBio) and the CFX 
Connect™ Real-Time PCR Detection System (Bio-Rad). Primers are described in Table 
1. The reaction schedule was as follows: 10 s, 95°C; 30 s, 60°C; 30 s, 72°C for 40 cycles. 
The level of mRNA was calculated using the ∆∆CT method and shown as fold-change 
relative to MCF-7 cells. Statistical analysis was performed using the Cq values, not the 
calculated fold-change. 
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Table 1. Primer sequences used for qPCR.  
 Forward Reverse 
MT1-
MMP 
5’-GCAGAAGTTTTACGGCTTGCA-3’ 
 
5’-TCGAACATTGGCCTTGATCTC-3’ 
 
GAPDH 5’-ACCCACTCCTCCACCTTTGA-3’ 
 
5’-CTGTTGCTGTAGCCAAATTCGT-3’ 
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2.9 Immunofluorescence microscopy and MT1-MMP signal 
area quantification  
MCF-7 cells were transfected with either FL MT1-MMP, MT2CD MT1-MMP or ∆CD 
MT1-MMP cDNA and incubated for 24 hours. Transfected cells were then seeded onto 
poly-L-lysine-coated glass coverslips (No. 0) and incubated for a further 24 hours. Cells 
were then fixed in 10% formaldehyde and blocked using 1% BSA in PBS (pH 7.2), the 
latter to prevent non-specific antibody binding. For immunofluorescence analysis cells 
were incubated for one hour at room temperature using rabbit anti-MT1-MMP (1:200, 
AB6004, Millipore), followed by one hour incubation with the secondary antibody anti-
rabbit-IgG-Alexa488 (Thermo Fisher, 1:400). F-actin was stained with Alexafluor633-
phalloidin (Thermo Fisher; 1:40 dilution) and nuclei stained with 4’,6-diamidino-2-
phenylindole (DAPI; 1 µL/mL, BioShop Canada). Coverslips were washed, mounted 
using ProLong Gold Antifade Mountant (Thermo Fisher), and imaged using a Nikon 
A1R+ confocal microscope using NIS Elements software (Nikon).  
Image analysis was performed using ImageJ software (U. S. National Institutes of Health, 
Bethesda, Maryland, USA). For signal area analysis, individual colour channels were 
isolated, converted to binary, and the area of isolated single cells measured using the 
software. The area of green channels, corresponding to MT1-MMP, was then divided by 
the signal area taken of the same cell on the red channel, representing F-actin. 
2.10 Fluorescent gelatin degradation assay 
To examine the proteolytic abilities of cells to degrade ECM substrates, cells were 
cultured on coverslips coated with Oregon Green 488 conjugated to porcine gelatin 
(Thermo Fisher). These were generated by the following protocol: coverslips were 
sterilized with 0.1 M sodium hydroxide, coated in poly-L-lysine, and fixed using 0.5% 
glutaraldehyde. Oregon green gelatin was diluted 1:8 in 0.2% untagged porcine gelatin 
(Sigma) in PBS. Droplets of this gelatin suspension were placed onto parafilm, and 
coverslips flipped and incubated on top of them for 10 minutes. These coated coverslips 
were washed in PBS, and stored in cold DMEM/F12 media with 10X non-essential 
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amino acids (Thermo Fisher). These amino acids quenched reactive oxygen species 
generated by glutaraldehyde to protect the integrity of the gelatin.  
MCF-7 cells were transfected with either GFP, MT1-MMP, MT2CD MT1-MMP or ∆CD 
MT1-MMP cDNA, and 25 000 cells were seeded onto gelatin slips. These were 
incubated for 24 hours, fixed in 10% formalin and permeabilized with 0.4% Triton X-
100. Slips were then prepared for immunofluorescence microscopy using DAPI (1 
µL/mL, BioShop Canada), Alexafluor633-phalloidin (Thermo Fisher, 1:40 dilution), and 
rabbit anti-MT1-MMP (Millipore, 1:200) with goat anti-rabbiti-IgG-Alexafluor594 
(Thermo Fisher, 1:400). Coverslips were washed, mounted using ProLong Gold Antifade 
Mountant (Thermo Fisher), and imaged using a Nikon A1R+ confocal microscope using 
NIS Elements software (Nikon). 
2.11 Transwell cell motility assays 
Cell motility of both transiently and stably transfected MCF-7 cells was assessed using 
24-well 8 µm pore transwell inserts (Corning Costar) using the method described by 
Marshall, 2011. Cells were seeded (20 000 cells/well) in the upper chamber of transwells 
in serum-free media and induced to migrate towards the lower chamber containing 
DMEM/F-12 media supplemented with 10% FBS. Cells were incubated for 48 hours. 
Migration assays were performed using uncoated transwell inserts, while invasion assays 
were performed by coating the upper chamber of transwells with 20% Matrigel (BD 
Biosciences). To quantify cell motility, cells were fixed in 100% methanol, and non-
motile cells remaining in the upper surface of the transwell removed with a damp cotton 
swab. Cells on the bottom of transwells were stained using a 0.5% solution of crystal 
violet in distilled water. These stained transwells were then individually destained in 33% 
acetic acid, and the absorbance of this solution at 490 nm was quantified using the 
Microplate Reader Model 3550-UV (BioRad) as a correlative measurement of cell 
number.   
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2.12 Wound closure migration assay 
The two dimensional motility of parental MCF-7 and the stable cell lines MT1-MMPst, 
MT2CD MT1-MMPst, and ∆CD MT1-MMPst was assessed using a wound closure assay. 
MT1-MMP-expressing stable cell lines or MCF-7 cells were seeded on a 35 mm cell 
culture dish (Corning) at confluency (5x105 cells/mL) and incubated for 24 hours. Using 
a 100 µL pipette tip, an area through the monolayer approximately 5 mm in width was 
cleared to create a “wound”, whose re-population and closure was subsequently 
monitored using bright-field microscopy (Leica DM16000 B microscope) for 72 hours. 
Wound closure was assessed using ImageJ software by measuring the width between the 
wound edges at each time point in captured images, and subtracting the initial wound size 
to calculate distance migrated.    
2.13 Measurements of cell proliferation 
Cell proliferation under serum-supplemented and serum-free conditions was assessed 
using CellTiter® 96 AQueous One Solution (Promega) as per manufacturer’s 
instructions. The CellTiter® protocol utilizes the tetrazolium compound [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, 
inner salt], which is reduced by metabolically active cells to a coloured quantifiable 
product, formazan. Parental MCF-7 cells and MT1-MMPst, MT2CD MT1-MMPst, ∆CD 
MT1-MMPst cell lines were seeded in triplicate in a 96 well culture plate at a density of 
5x104 cells/mL in either serum-free media or media supplemented with 10% FBS and 
incubated for nine days. Immediately after seeding and at three day intervals, CellTiter® 
reagent was added to culture wells and incubated at 37°C for 2 hours. Absorbance at 490 
nm was then measured using Microplate Reader Model 3550-UV (BioRad), and was used 
a measurement of the number of living cells in culture.   
In addition, phospho-histone 3 protein was collected from cells incubated for six days in 
either serum-supplemented or serum-free media. 1.6 x 105 cells were seeded onto a 6-well 
culture dish for protein collection. As many cells remained loosely attached after six days 
of serum-starvation, cells were immediately treated with lysis buffer rather than initially 
washed with PBS.  
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2.14 Cell viability and apoptosis 
Parental MCF-7 cells and MT1-MMPst, MT2CD MT1-MMPst, ∆CD MT1-MMPst cell 
lines were seeded in triplicate in a 96 well culture plate at a density of 5x104 cells/mL in 
either serum-free media or media supplemented with 10% FBS and incubated for six 
days, and their viability and caspases activity were assessed using the ApoTox-Glow 
Triplex Assay (Promega) as per manufacturer’s instructions. To assess cell viability, cells 
were treated with the cell-permeable GF-AFC fluorescent substrate (5.0 nM) and 
incubated at 37°C for 1 hour, and fluorescence measured using Tecan Infinite M1000 
with Magellan 7 software (400Ex/505Em). Cells were then immediately assayed for 
apoptosis via treatment with a luminogenic substrate containing the DEVD sequence 
susceptible to cleavage by caspases 3 and 7. After one hour of incubation at 37°C, 
luminescence was measured using Modulus™ II Microplate Multimode Reader and 
GloMax® - Multi Detection System with Instinct® software as a metric of apoptosis.   
2.15 Three-dimensional (3D) cell culture 
MCF-7 cells and MT1-MMP-expressing stable cell lines MT1-MMPst, MT2CD MT1-
MMPst and ∆CD MT1-MMPst were cultured in a 3D Matrigel matrix to assess 
morphological features as described by Cvetković, Goertzen, & Bhattacharya, 2014. 
Glass-bottom cell culture dishes (MatTek) were prepared by coating the glass with 50% 
Matrigel (BD Biosciences) in serum-free media, allowing the matrix to solidify, and 
seeding 2.5x104 cells in 50% Matrigel in serum-free media above this layer to result in 
cells completely suspended in matrix. Cultures were incubated in either serum-
supplemented (10% FBS) or serum-free conditions. Cell colony morphology was 
monitored for five days using bright-field microscopy (Leica DM16000 B microscope 
with Leica DFC425 camera) at 10X magnification, and representative 50 µm z-stack 
images (2 µm interval) taken at random locations across the matrix were captured using 
Leica MMAF software (Metamorph®). After five days, cells within the matrix were 
fixed using 20% acetone, 80% methanol and prepared for immunofluorescence using 
Alexafluor633 phalloidin (Thermo Fisher, 1:100) and DAPI (1 µL/mL, BioShop Canada) 
to examine F-actin and nuclei, respectively. Prepared samples were imaged using a Nikon 
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A1R+ confocal microscope and NIS Elements software (Nikon), capturing Z-stacks of 
approximately 100 µm.  
To quantify the morphology of cell colonies, images were analyzed blindly using ImageJ 
software. Images containing fewer than 8 colonies were excluded from analysis. Cellular 
protrusions were defined as discrete, unbranched extensions of a given length that 
emanated from a round cell colony. The number of protrusions on all cell colonies in an 
image were counted, with longer protrusions counted as multiples of the average 
protrusion length seen in that image to adjust for the heterogeneity in size observed. The 
score, representing the total number of protrusions, was divided by the total number of 
colonies to arrive at the final measurement of protrusions per colony. In serum-free 
conditions, the additional measurement of fractured colony morphology was counted. 
Fractured colonies were defined as having multiple small vesicles surrounding a central 
colony. The number of fracturing colonies is reported as a percentage of total colonies.  
2.16 Firefly luciferase transcriptional activity analysis 
MT1-MMPst, MT2CD MT1-MMPst, ∆CD MT1-MMPst and MCF-7 cells were seeded at 
a density of 3000 cells/well in a 96-well culture plate (Corning) and incubated for 24 
hours. Following the method previously described, cells were transfected with 0.2 µg of 
mammalian 3xAP1pGL3 (addgene, Plasmid #40342) or p1242 3xKB-L (addgene, 
Plasmid #26699) luciferase expression plasmids to detect the transcriptional activity of 
AP-1 and NF-кB transcription factors, respectively. Twenty four hours post transfection, 
cells were lysed and treated with Firefly Luciferase Glow Assay reagents (Thermo 
Fisher) according to manufacturer’s instructions. Luminescence was detected using 
Modulus™ II Microplate Multimode Reader and GloMax® - Multi Detection System 
with Instinct® software. 
2.17 Avian embryo tumour vascularization assay  
The vascularization of artificial tumours of ZsGreen-tagged ZsMCF-7, ZsMT1-MMPst, 
ZsMT2CD MT1-MMPst and Zs∆CD MT1-MMPst cells in Matrigel was assessed in avian 
embryos following the technique developed by Dr. Hon Leong, Western University. 
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Embryos, materials and facilities were generously provided by Dr. Hon Leong, Western 
University. Chick embryos were incubated in culture boats for nine days at 37°C in a 
humidified chamber. A superficial wound was introduced to the vasculature of the 
chorioallantoic membrane (CAM) of embryos and 10 µL of Matrigel containing ~500 
000 cells was injected into the wound. Embryos were incubated for a further eight days, 
and tumours were examined using fluorescent stereomicroscopy to assess if vasculature 
had developed at the tumour site. Vascularization was determined to have occurred if the 
wound site showed capillaries associated with a tumour which had successfully grown 
beneath the CAM layer. This was accomplished by comparing observed vasculature 
using bright field microscopy to areas of contrast observed under fluorescent conditions. 
Vascularization was quantified as a binary measurement, indicated by the presence or 
absence of tumour-localized vasculature in individual embryos.  
2.18 Immunoblot densitometry analysis 
Quantitative densitometric analysis of immunoblots was performed using QuantityOne 
software (Bio-Rad). Band intensity was calculated for MT1-MMP, phospho-Histone 3 
and β-actin using three independent biological samples. Intensity is shown as a ratio of 
MT1-MMP signal standardized to the β-actin signal and then compared to control 
conditions. 
2.19 Statistics 
Statistical analysis and graphing was performed using GraphPad Prism version 6.0 
(GraphPad software, La Jolla, CA USA). Data is presented as mean ± SEM. Means were 
compared using one-way ANOVA followed by Tukey’s post-hoc test, with levels of 
statistical significance identified as follows: ****, p ≤ 0.0001, ***, p ≤ 0.001, **, p ≤ 
0.01, *, p ≤ 0.05. 
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Chapter 3  
3 Results 
3.1 Cytoplasmic domain deletion or substitution altered the 
activation profile of MT1-MMP protein in transiently 
transfected breast cancer cells.  
To determine the role of the cytoplasmic domain in MT1-MMP protein activation, MCF-
7 cells were transiently transfected with FL MT1-MMP, MT2CD MT1-MMP, or ∆CD 
MT1-MMP cDNA, or GFP cDNA as a control, lysed, and whole-cell lysate subject to 
SDS-PAGE and western blot analysis. The activation profile, a description of the levels 
of pro-, active, and degraded isoforms of MT1-MMP, was assessed for each construct. 
MCF-7 cells, which are deficient in MT1-MMP (Figueira et al., 2009), showed no 
detectable levels of MT1-MMP protein (Figure 2 a). MCF-7 cells expressing FL MT1-
MMP showed an activation profile of MT1-MMP protein which included the pro- (63 
kDa) and active (60 kDa) forms, as well as a 44 kDa degradation product (Cho et al., 
2008). Transfection with MT2CD MT1-MMP resulted in levels of pro-MT1-MMP 
protein that were not significantly different from FL MT1-MMP expressing cells; 
however there was significantly less active MT1-MMP (p < 0.05) and no degradation 
product was observed (Figure 2 b). Transfecting MCF-7 cells with ∆CD MT1-MMP 
resulted in significantly higher levels of a lower molecular weight (59 kDa) truncated 
form of pro-MT1-MMP, as compared to FL MT1-MMP transfection (p < 0.01). In 
addition, ∆CD MT1-MMP transfection also resulted in the generation of a smaller active 
form of MT1-MMP (56 kDa), and no observed degradation product.   
The difference in the activation profiles of MT1-MMP following transfection with 
MT2CD MT1-MMP and ∆CD MT1-MMP cDNAs - which despite both having altered 
cytoplasmic domains showed an absence or presence of active MT1-MMP, respectively - 
was further examined by considering alternative methods of protein activation aside from 
the well-documented furin-mediated cleavage of pro-MT1-MMP. As MMP members are 
capable of auto-activation (Kang, Nagase, & Pei, 2002), MMP-mediated activation was 
explored as a possible reason for the activation of MT1-MMP protein following transient  
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Figure 2. Cytoplasmic domain-altered MT1-MMP proteins showed different 
activation profiles and were activated differently in transiently transfected breast 
cancer cells.  
(a) Western blot analysis was performed to examine the activation profiles and protein 
levels of MT1-MMP in MCF-7 cells transfected with FL MT1-MMP, MT2CD MT1-
MMP, or ∆CD MT1-MMP constructs, or a control GFP plasmid. FL MT1-MMP 
transfection resulted in the generation of the 63 kDa pro- and 60 kDa active forms of the 
protein. MT2CD MT1-MMP transfects showed bands of active MT1-MMP with 
significantly less intensity (p < 0.05) than FL MT1-MMP. ∆CD MT1-MMP transfection 
resulted in significantly higher levels of a truncated pro-MT1-MMP protein (59 kDa) as 
compared to FL MT1-MMP (p < 0.01). Only cells transfected with FL MT1-MMP 
showed the 44 kDa MT1-MMP degradation product. β-actin is shown as a loading 
control. (b) Three independent protein samples were examined by western blot and 
subject to densitometry analysis. MT1-MMP protein band densities were standardized to 
β-actin, and control cells. Means are presented ± SEM, and were compared using one-
way ANOVA; different letters of same case signify differences at p < 0.05. (c) Western 
blot analysis of MCF-7 cells treated with the pan-MMP inhibitor BB-94 and subsequently 
transfected with FL MT1-MMP or ∆CD MT1-MMP cDNA. With increasing 
concentration of BB-94, the levels of active ∆CD MT1-MMP protein decreased, and 
were significantly lower than DMSO treated cells after 30 µM treatment (p < 0.05). BB-
94 treatment had no effect on levels of active MT1-MMP protein following FL MT1-
MMP transfection. (d) Three independent protein samples were examined by western 
blot for levels of active MT1-MMP protein and subject to densitometry analysis. Pro and 
active-MT1-MMP band densities were normalized to β-actin, and DMSO treated cells. 
Means are presented ± SEM, and were compared using one-way ANOVA; different 
letters of same case signify differences at p < 0.05. (e) Western blot analysis of MT1-
MMP protein from MDA-MB-231 breast cancer cells transfected with MT1-MMP 
cytoplasmic domain-altered constructs or GFP (control). MDA-MB-231 cells 
constitutively express MT1-MMP, mostly in the active form. FL MT1-MMP transfection 
resulted in an increase in the levels of both the pro- and active form of the protein, while 
transfection with MT2CD MT1-MMP resulted only in an increase of pro-MT1-MMP. 
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∆CD MT1-MMP showed a significant increase in the level of pro-MT1-MMP as 
compared to control or FL MT1-MMP transfected cells (p < 0.001). (f) Three 
independent protein samples were examined by western blot for levels of pro- and active 
MT1-MMP protein and subject to densitometry analysis. Band densities were normalized 
to β-actin, and control cells. Means are presented ± SEM, and were compared using one-
way ANOVA; different letters of same case signify differences at p < 0.001. 
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transfection of ∆CD MT1-MMP in MCF-7 cells. MCF-7 cells were transiently 
transfected with either FL MT1-MMP or ∆CD MT1-MMP and treated with BB-94, a 
pan-MMP inhibitor molecule. Western blot analysis of lysate from these cells show that  
BB-94 treatment significantly decreased by approximately 360%  the level of active 
MT1-MMP in ∆CD MT1-MMP transfected cells (p < 0.05), while the level of active 
MT1-MMP in FL MT1-MMP cells was not altered by the treatment (Figure 2 c, d).   
Considering the abundance of distinct breast cancer cell lines, which correspondingly 
show variation in MT1-MMP expression levels and protein activation profiles, MT1-
MMP constructs were also transfected into MDA-MB-231 cells (Figure 2 e, d). These 
human breast cancer cells, which naturally express high levels of MT1-MMP, were used 
to confirm that observations were not cell-line specific. Transfection with a control GFP 
plasmid demonstrated that MDA-MB-231 cells endogenously produce MT1-MMP 
protein, most of which present in its active form. Transfection with FL MT1-MMP 
increased the levels of both pro- and active MT1-MMP protein relative to GFP 
transfection. Transfection with MT2CD MT1-MMP resulted only in the increase of pro-
MT1-MMP protein levels, a result similar to what was observed in MCF-7 cells. ∆CD 
MT1-MMP transfection resulted in a significant increase in the level of pro-MT1-MMP 
protein relative to all other constructs (p < 0.001). 
3.2 Deletion or substitution of the cytoplasmic domain of 
MT1-MMP affected its cell surface localization in 
transiently transfected MCF-7 cells.  
To assess the cell surface protein localization of MT1-MMP and cytoplasmic domain 
mutants of MT1-MMP, MCF-7 cells were transiently transfected and assessed by 
immunofluorescence microscopy. The cell surface distribution of MT1-MMP protein 
showed distinct and different patterns following transfection with either FL MT1-MMP, 
MT2CD MT1-MMP or ∆CD MT1-MMP (Figure 3 a). In mock transfected cells, very 
little MT1-MMP protein was observed, consistent with the low endogenous expression in 
this cell line. Transfection with FL MT1-MMP resulted in a distribution of MT1-MMP 
protein that localized to the periphery of cells in a pattern similar to F-actin. In contrast,  
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Figure 3. Alteration to the cytoplasmic domain of MT1-MMP disrupted its cell 
surface localization in transiently transfected MCF-7 breast cancer cells.  
(a) Confocal microscopy images of cells transfected with MT1-MMP constructs and 
stained with MT1-MMP specific antibodies. Confocal microscopy images are displayed 
as merged images of MT1-MMP protein (green), F-actin (red), and nuclei (blue) (top 
panels) and as isolated MT1-MMP signal (middle panels). Mock-transfected cells 
showed little MT1-MMP protein, while transfected cells showed a cell surface 
distribution of MT1-MMP protein that differs depending on the nature of the cytoplasmic 
domain mutation. FL MT1-MMP transfection resulted in widespread distribution of 
MT1-MMP at the cell surface, while MT2CD MT1-MMP transfection showed a 
filamentous distribution pattern. ∆CD MT1-MMP transfection resulted in dense puncta of 
MT1-MMP signal at the surface of cells. In addition, neither MT2CD MT1-MMP nor 
∆CD MT1-MMP transfection resulted in cell surface MT1-MMP protein localized to 
actin-containing protrusions, while MT1-MMP in FL MT1-MMP cells did localize to 
these peripheral structures. This phenomenon is highlighted in the inset images, where 
white arrows indicate distal, actin-rich cell surfaces (A1) and the closest MT1-MMP 
signal (A2). (b) The degree of co-localization of MT1-MMP with F-actin in individual 
transfected cells was quantified to assess the variation in patterns of MT1-MMP 
localization observed. Using ImageJ software, the signal area of MT1-MMP in an entire 
cell was divided by that of F-actin in individual cells to calculate a co-localization ratio. 
Both MT2CD MT1-MMP (p < 0.01) and ∆CD MT1-MMP (p < 0.0001) transfected cells 
show significantly less co-localization of MT1-MMP signal area compared to F-actin 
than do FL MT1-MMP transfected cells. Means are presented as relative signal area + 
SEM and were compared using one-way ANOVA; *** p ≤ 0.001. Scale bars = 50 µm.  
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neither MT2CD MT1-MMP nor ∆CD MT1-MMP transfection resulted in peripheral 
MT1-MMP protein localization. Notably, MT1-MMP protein was not observed at the 
distal ends of actin-rich cell extensions in cells transfected with MT2CD MT1-MMP or 
∆CD MT1-MMP, while this was observed following FL MT1-MMP transfection. 
Additionally, while the pattern of labelled MT1-MMP protein had relatively uniform 
intensity following FL MT1-MMP transfection, this patterning was more diffuse with 
MT2CD MT1-MMP and punctate following ∆CD MT1-MMP transfection. The patterns 
of MT1-MMP protein distribution observed were confirmed to be cell surface as separate 
experiments using Triton X-100 to permeablize cell membranes showed different 
fluorescence patterns; notably distinct fluorescent puncta in all conditions. Additionally, 
secondary antibody-only treatment showed no fluorescent signal (data not shown). 
This cortical localization of MT1-MMP protein was quantified by measuring and 
comparing the fluorescence signal area of MT1-MMP in captured images to the 
fluorescence signal area of F-actin, which was taken to represent the total cell surface 
area, to generate the relative signal area of MT1-MMP (Figure 3 b). Following FL MT1-
MMP transfection, the degree of MT1-MMP and F-actin co-localization was significantly 
greater than that observed following MT2CD MT1-MMP (p < 0.01) and ∆CD MT1-
MMP (p < 0.0001) transfection, representative of the disruption in protein localization 
that was observed.  
3.3 Alteration to the cytoplasmic domain by deletion or 
substitution abolished MT1-MMP-mediated pro-MMP-2 
activation and gelatin degradation.  
Having observed irregular protein activation profiles upon cytoplasmic domain alteration 
to MT1-MMP, the proteolytic activity of the MT1-MMP protein generated from these 
constructs was assessed. First, the ability of MT1-MMP to activate pro-MMP-2 was 
examined using gelatin zymography. MCF-7 cells, which are deficient in MMPs and 
TIMPs, were transfected with FL MT1-MMP, MT2CD MT1-MMP, ∆CD MT1-MMP, or 
GFP, and incubated with control media or conditioned media containing pro-MMP-2 for 
12 hours. Subsequent examination of culture media by gelatin zymography showed that 
upon incubation with pro-MMP-2, only the media from cells transfected with FL MT1-  
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MMP contained the intermediate and active forms of MMP-2 (Figure 4). As the process 
of MT1-MMP-mediated activation of pro-MMP-2 is enhanced by the addition of low 
levels of TIMP-2 (Itoh et al., 2001), TIMP-2 conditioned media was also added. 
Incubation with pro-MMP-2 and TIMP-2 did increase the levels of intermediate and 
active MMP-2 in FL MT1-MMP-transfected cells as expected, but did not enhance pro-
MMP-2 protein activation in cells transfected with MT2CD MT1-MMP or ∆CD MT1- 
MMP. The addition of the MMP inhibitor BB-94 during incubation effectively attenuated 
pro-MMP-2 activation in FL MT1-MMP transfected cells, illustrating that this process 
required both the catalytic activity and the cytoplasmic domain of MT1-MMP.  
The ability of cells expressing MT1-MMP or cytoplasmic domain-altered forms of MT1-
MMP to degrade ECM substrates was further examined by assessing the degradation of a 
fluorescent gelatin substrate. MCF-7 cells were transiently transfected with MT1-MMP 
constructs and seeded onto glass coverslips that had been coated with fluorescent gelatin, 
incubated for 48 hours, and prepared for fluorescence confocal microscopy. The ability of 
cells to degrade this substrate could be assessed by observing black holes within the 
green fluorescent gelatin, representing an absence of fluorescent signal. While MT1-
MMP protein (red) was observed to co-localize with actin puncta (purple) in cells 
following transfection with either FL MT1-MMP, MT2CD MT1-MMP or ∆CD MT1-
MMP, only cells transfected with FL MT1-MMP exhibited degradation of the underlying 
gelatin matrix (Figure 5).   
3.4 Deletion or substitution of the cytoplasmic domain of 
MT1-MMP increased cell migration and invasion in 
transiently transfected MCF-7 cells  
As transfection with the different MT1-MMP constructs resulted in aberrant protein 
localization and different abilities of MT1-MMP to degrade ECM, the migratory and 
invasive capabilities of transfected cells was investigated. Migration was defined in this 
assay as unobstructed cell movement, while invasion involved cell movement through the 
biological barrier of Matrigel. MCF-7 cells were transiently transfected with GFP, FL 
MT1-MMP, MT2CD MT1-MMP or ∆CD MT1-MMP and the migratory and invasive 
abilities of cells assessed using a transwell assay (Figure 6). Significantly more cells  
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Figure 4. Substitution or deletion of the cytoplasmic domain of MT1-MMP 
disrupted MT1-MMP-mediated activation of pro-MMP-2 in transiently transfected 
MCF-7 cells. 
Cells were transfected with MT1-MMP constructs, incubated for 24 hours, and subject to 
12 hour treatment with serum-free conditioned media (CM) in order to examine the 
activation of pro-MMP-2 using gelatin zymography. Bands of degraded gelatin show the 
location of renatured MMPs. Cells transfected with FL MT1-MMP show low levels of 
active MMP-2 protein following incubation with control media (Control, top). After 
incubation with exogenous pro-MMP-2 conditioned media, FL MT1-MMP transfection 
resulted in high levels of the intermediate and active forms of MMP-2 (second from top). 
Addition of TIMP-2 during incubation did not enhance the activation of pro-MMP-2 in 
MT2CD MT1-MMP or ∆CD MT1-MMP transfected cells, but did increase the levels of 
intermediate and active MMP-2 proteins in FL MT1-MMP transfected cells (second from 
bottom). Treatment with BB-94, an MMP inhibitor, during incubation effectively 
attenuated MMP-2 activation in FL MT1-MMP transfected cells (bottom). 
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Figure 5. Substitution or deletion to the cytoplasmic domain of MT1-MMP 
disrupted MT1-MMP-mediated gelatin degradation. 
Confocal microscopy images of transfected MCF-7 cells (FL MT1-MMP, MT2CD MT1-
MMP, ∆CD MT1-MMP or mock) seeded and incubated on an Oregon Green-tagged 
gelatin substrate. MT1-MMP puncta co-localized with actin puncta in all transfected cells 
(merged images, pink). However, only FL MT1-MMP-expressing cells showed gelatin 
degradation at sites corresponding to the location of transfected cells (black holes within 
green substrate). White arrows indicating the location of MT1-MMP are transposed 
across all images. Images taken at 60x magnification, scale bars = 50 µm. 
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Figure 6. Substitution or deletion of the cytoplasmic domain of MT1-MMP 
increased the migration and invasion of transfected MCF-7 breast cancer cells. 
(a) To examine migration, cells were transfected with GFP (control), FL MT1-MMP, 
MT2CD MT1-MMP, or ∆CD MT1-MMP cDNA, incubated for 24 hours, and seeded into 
the upper chamber of a transwell insert in serum-free media. Cells were induced to 
migrate towards the serum-supplemented media in the lower chamber. After 48 hours, 
successfully migrated cells were quantified and compared to control cells. Significantly 
more MT2CD MT1-MMP and ∆CD MT1-MMP transfected cells migrated through the 
transwell pores than did control cells (p < 0.05). FL MT1-MMP transfection resulted in 
no significant difference in migration compared to GFP cells (p > 0.05). The results of 
three biological replicates are presented as mean relative absorbance + SEM, and were 
compared using one-way ANOVA; different letters signify differences at p < 0.05. (b) To 
examine invasion, a similar protocol was employed as above with the modification that 
the upper surface of transwells were coated in 20% Matrigel to provide a physical barrier 
to motility. Significantly more cells transfected with MT2CD MT1-MMP or ∆CD MT1-
MMP invaded through the Matrigel and transwell pores than did control cells (p < 0.001). 
Cells transfected with FL MT1-MMP showed no significant difference in invasion 
compared to GFP cells. The results of three biological replicates are presented as mean 
relative absorbance + SEM, and were compared using one-way ANOVA; different letters 
signify differences at p < 0.001.  
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migrated following transfection with either MT2CD MT1-MMP (~24% increase) or ∆CD 
MT1-MMP (~18% increase) compared to control or FL MT1-MMP transfected cells (p < 
0.05; Figure 6 a). Similarly, transfection with MT2CD MT1-MMP significantly increased 
the number of invaded cells by ~104%, while ∆CD MT1-MMP increased this number by 
84%, as compared to control transfected cells (p < 0.001; Figure 6 b), while FL MT1-
MMP transfected cells showed a 14% increase in cell invasion compared to control cells. 
3.5 Stable expression of MT2CD MT1-MMP or ∆CD MT1-
MMP in MCF-7 cells did not result in gelatin 
degradation but increased cell migration 
Due to the potentially confounding effects of artificially high and brief MT1-MMP 
expression in transiently transfected cells, MCF-7 cell lines were generated which stably 
expressed FL MT1-MMP, MT2CD MT1-MMP and ∆CD MT1-MMP to observe protein 
activity in a more regulated setting. These cell lines, called MT1-MMPst, MT2CD MT1-
MMPst and ∆CD MT1-MMPst were confirmed to have both increased expression of MT1-
MMP and increased amount of MT1-MMP protein as compared to parental cells, 
assessed by qPCR and western blot respectively (Figure 7 a, b).  
These stable cell lines were seeded on fluorescent gelatin-coated coverslips and incubated 
for 48 hours to detect matrix degradation. As was observed following transient 
transfection, only MT1-MMPst cells exhibited gelatin degradation (Figure 7 c). In 
addition, MT1-MMP protein in all of MT1-MMPst, MT2CD MT1-MMPst and ∆CD 
MT1-MMPst co-localized with actin puncta in cells, a pattern consistent with results from 
transient transfection.  
The migratory capability of stable cell lines was also assessed to compare with the results 
obtained following transient transfection. First, a wound closure assay was conducted 
whereby cells were allowed to grow to confluence and a wound was introduced to disrupt 
the monolayer. The closure of the wound was monitored over three days and used as a 
metric of cell migration. All of MT1-MMPst (~42% increase), MT2CD MT1-MMPst 
(~43% increase) and ∆CD MT1-MMPst (~54% increase) cells migrated significantly 
further into the wound at all time points than did MCF-7 parental cells (p < 0.001),  
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Figure 7. MCF-7 cell lines stably expressing FL MT1-MMP, MT2CD MT1-MMP 
and ∆CD MT1-MMP showed different gelatin degradation capabilities. 
MCF-7 cells were transfected and selected for stable plasmid integration and increased 
expression of MT1-MMP. Successful individual clones were isolated and called MT1-
MMPst, MT2CD MT1-MMPst, ∆CD MT1-MMPst. (a) qPCR analysis of stable cell lines 
showed that MT1-MMPst (p < 0.05) MT2CD MT1-MMPst (p < 0.0001) and ∆CD MT1-
MMPst (p < 0.0001) expressed MT1-MMP at significantly higher levels than parental 
MCF-7 cells. The results of three biological replicates are shown as mean fold-change ± 
SEM, and differences assessed using one-way ANOVA; different letters signify 
differences at p < 0.05. (b) Stable cell lysates were collected and subject to 
immunoprecipitation to detect MT1-MMP protein levels. Both MT2CD MT1-MMPst and 
∆CD MT1-MMPst showed increased levels of MT1-MMP protein compared to parental 
cells. The high-expressing MT1-MMPH cell line was used as a positive control. Pulldown 
(PD) immunoprecipitation with a control, normal rabbit species IgG showed no MT1-
MMP protein when subsequently probed. (c) Stable cell lines MT1-MMPst, MT2CD 
MT1-MMPst, ∆CD MT1-MMPst and MCF-7 cells were seeded on Oregon Green-tagged 
gelatin and prepared for immunofluorescence using confocal microscopy. Merged images 
show MT1-MMP (red), F-actin (purple) and nuclei (blue; top panels). All of MT1-
MMPst, MT2CD MT1-MMPst, ∆CD MT1-MMPst showed a punctate pattern of MT1-
MMP protein, which co-localizes with actin puncta (pink signal, top panels). Only MT1-
MMPst cells showed degradation of gelatin substrate, indicated by black holes that 
correspond to cells expressing MT1-MMP. White arrows indicating the location of MT1-
MMP are transposed across all images. Images taken at 60x magnification, scale bars = 
50 µm. 
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though they were not significantly different from each other (Figure 8 a, b). To 
corroborate this result, a transwell migration assay was also performed. After 48 hours of 
incubation, significantly more MT1-MMPst (~19% increase, p < 0.01), MT2CD MT1-
MMPst (~14% increase) and ∆CD MT1-MMPst (~15% increase; p < 0.05) cells migrated 
than parental MCF-7 cells (Figure 8 c). Stable MT1-MMP expressing MCF-7 cell line 
data thus demonstrated that while the cytoplasmic domain of MT1-MMP was required 
for substrate proteolysis, it was dispensable in mediating cell migration. 
3.6 MT1-MMP expression induced a protrusive phenotype 
in MCF-7 cell lines grown in 3D culture regardless of 
mutations to the cytoplasmic domain  
To examine how cell morphology may contribute to the increased cell migration capacity 
observed in MCF-7 cell lines stably expressing cytoplasmic domain-altered forms MT1-
MMP, cells were incubated within a 3D matrix composed of Matrigel. Over five days, 
cell colonies embedded in this matrix were imaged and the morphology of cells was 
assessed. A recurring phenotype observed were cellular protrusions extending from 
individual cells within colonies (Figure 9 a). In all cell lines, the number of protrusions 
per colony increased with incubation time (Figure 9 b). However, MT2CD MT1-MMPst 
and ∆CD MT1-MMPst cells showed significantly more protrusions per colony, 
approximately an 3.8-fold increase than MCF-7 cells on day two of incubation (p < 0.05), 
while MT1-MMPst cells were not significantly different than parental cells at this time 
point. By day five MT2CD MT1-MMPst (p < 0.001) and ∆CD MT1-MMPst (p < 0.01) 
cells continued to show significantly more protrusions per colony than parental MCF-7 
cells, at ~3-fold and ~2.3 increases respectively, and while not significant MT1-MMPst 
cells showed approximately twice as many protrusions per colony than MCF-7 colonies.  
After five days of incubation, samples were fixed and prepared for immunofluorescence 
microscopy to examine nuclei and F-actin structures within cells and colonies. Confocal 
microscopy images showed that the protrusions observed in 3D culture were rich in F-
actin, and were clearly distinguished in colonies of MT1-MMPst, MT2CD MT1-MMPst 
and ∆CD MT1-MMPst cells (Figure 9 c).   
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Figure 8. Deletion or substitution of the cytoplasmic domain of MT1-MMP did not 
impair MT1-MMP-mediated cell migration in stably expressing MCF-7 cell lines. 
(a) Bright-field microscopy images of MCF-7 and MT1-MMPst, MT2CD MT1-MMPst, 
∆CD MT1-MMPst cell lines immediately following and 72 hours after monolayer 
disruption in a wound closure assay. Cells were seeded at confluence, incubated for 24 
hours, and the monolayer disrupted. The closure of this wound was observed for 72 hours 
using bright-field microscopy. Representative images of the wound are shown, where 
thin lines mark initial wound edges and thick lines indicate the final wound front. Scale 
bars = 200 µm. (b) Images were taken along the length of the wound immediately after 
wounding and at 24, 48 and 72 hours. The distance between the wound edges at each 
time point was measured and subtracted from the initial wound size to calculate distance 
migrated. After 72 hours, the distance migrated by MT1-MMPst, MT2CD MT1-MMPst, 
and ∆CD MT1-MMPst cells was not significantly different, though they all migrated 
significantly more (p < 0.0001) than parental MCF-7 cells. The results of four biological 
replicates are presented as mean distance ± SEM, and differences measured using one-
way ANOVA; **** p ≤ 0.0001. (c) The migration of MT1-MMP stable cell lines was 
assessed using a transwell migration assay. MT1-MMPst, MT2CD MT1-MMPst, ∆CD 
MT1-MMPst and parental cells were seeded and induced to migrate along a vertical 
serum gradient. While there was no significant difference in the number of migrated cells 
among MT1-MMPst, MT2CD MT1-MMPst, and ∆CD MT1-MMPst, significantly more 
MT1-MMPst (p < 0.01), MT2CD MT1-MMPst (p < 0.05), and ∆CD MT1-MMPst (p < 
0.05) cells migrated through the transwell pores than MCF-7 cells. The results of three 
independent experiments are presented as mean relative absorbance ± SEM, and 
differences measured using one-way ANOVA; different letters signify differences at p < 
0.05 according to Tukey’s B test. 
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Figure 9. Alteration to the cytoplasmic domain of MT1-MMP exacerbated a 
protrusive cell morphology in 3D culture. 
(a) Bright field microscopy images of MCF-7 and MT1-MMPst, MT2CD MT1-MMPst, 
and ∆CD MT1-MMPst cells seeded in 3D Matrigel after five days of incubation. MT1-
MMPst, MT2CD MT1-MMPst, and ∆CD MT1-MMPst cell colonies all displayed discrete 
cellular protrusions of diverse length and number (inset, indicated by white arrows), 
while MCF-7 cell colonies remained mostly round. (b) These cellular protrusions were 
quantified and standardized to cell number, shown as protrusions per colony. In all cell 
lines, the number of protrusions per colony increased from day one to day five. As early 
as day two, both MT2CD MT1-MMPst and ∆CD MT1-MMPst cell colonies showed 
significantly more protrusions per colony than did MT1-MMPst or MCF-7 cells (p < 
0.05).  On day five, MT2CD MT1-MMPst (p < 0.001) and ∆CD MT1-MMPst (p < 0.01) 
colonies remained significantly more protrusive than MCF-7 cells. While not significant, 
the number of cell protrusions per colony in MT1-MMPst cells was higher than MCF-7 
cells. Different letters of the same case signify differences at p < 0.05 according to 
Tukey’s B test (c) 3D reconstruction images of z-stacks captured using confocal 
microscopy on cells grown in 3D culture. MCF-7 and MT1-MMPst, MT2CD MT1-
MMPst, and ∆CD MT1-MMPst cells were cultured in Matrigel for five days and prepared 
for immunofluorescence to identify F-actin (red) and nuclei (blue). Maximum signal 
intensity projections of captured images showed that MT1-MMPst, MT2CD MT1-MMPst, 
and ∆CD MT1-MMPst cell colonies display actin-rich cellular extensions similar to those 
observed under light microscopy (white arrows).  
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3.7 Alteration to the MT1-MMP cytoplasmic domain 
impaired MT1-MMP-mediated cell proliferation and 
viability, and abolished the anti-apoptotic effects of 
MT1-MMP upon serum starvation in 2D and 3D cell 
culture 
The effect of serum starvation as a cell stress condition was assessed in stable cell lines 
MT1-MMPst, MT2CD MT1-MMPst and ∆CD MT1-MMPst to gain an understanding of 
the non-proteolytic functions of MT1-MMP. First, cell proliferation was examined using 
the CellTiter® reagent under both serum-supplemented (10% FBS) and serum-free 
conditions for nine days. Growth in serum supplemented conditions resulted in no 
significant differences in measured cell proliferation among cell lines at day six, a time 
point in which peak proliferation occurred in all cell lines (Figure 10 a). To corroborate 
this result, protein was collected from cells grown for six days in serum-supplemented 
conditions and subject to western blot analysis to examine levels of phospho-histone 3, a 
marker of cell proliferation. Levels of phospho-histone 3 protein were not significantly 
different among cell lines at this time point (Figure 10 c, f). Interestingly, by day nine 
only MT1-MMPst cells were viable and showed continued significantly elevated levels of 
proliferation (p < 0.001). 
In contrast to the similarity in proliferation observed between cell lines cultured with 
serum, in serum-free conditions MT1-MMPst cells exhibited significantly more 
proliferation at levels ~2.9 fold greater than MCF-7 cells after three days in culture, and 
continued to be significantly more proliferative than all other cell lines at every time 
point (p < 0.0001) (Figure 10 b). Additionally, at day six, MT2CD MT1-MMPst cells 
proliferated significantly more than MCF-7 or ∆CD MT1-MMPst cells (p < 0.0001), 
though still significantly less proliferative than MT1-MMPst cells (p < 0.0001). ∆CD 
MT1-MMPst cells showed no significant difference in proliferation compared to parental 
MCF-7 cells at all time points. Corroborating these observations, levels of phospho-
histone 3 protein after six days of serum-free incubation were significantly greater by ~2 
fold in MT1-MMPst cells (p < 0.01) and lower in ∆CD MT1-MMP cells by ~-1.67 fold 
than in MCF-7 cells (Figure 10 d, e). 
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Figure 10. Mutation to the cytoplasmic domain of MT1-MMP in stably expressing 
MCF-7 cells decreased cell proliferation in serum-free stress conditions. 
(a, b) MT1-MMPst, MT2CD MT1-MMPst, ∆CD MT1-MMPst, or parental cells were 
seeded at 5000 cell/well onto a 96-well culture dish in either serum-free or serum-
supplemented media conditions. The proliferation of cells was measured in both 
conditions using CellTiter96® Aqueous One Solution (Promega) reagent for nine days. 
(a) In serum-supplemented conditions, the proliferation of all cell lines was not 
significantly different at day six, the day of peak proliferation. Nine days post-seeding, 
MT1-MMPst cells showed significantly more proliferation than any other cell lines (p < 
0.001). (b) In serum-free conditions, MT1-MMPst cells showed significantly more 
proliferation than all other cell lines at all time points after day zero (p < 0.0001). 
MT2CD MT1-MMPst cells showed significantly higher levels of proliferation (p < 
0.0001) at day six than MCF-7 and ∆CD MT1-MMPst, which were not significantly 
different from each other. The results of three independent experiments are presented as 
mean ± SEM, and were analyzed using one-way ANOVA; *** p ≤ 0.001; **** p ≤ 
0.0001. (c, d, e, f) Stably expressing MCF-7 cell lines were seeded in either serum-free or 
serum supplemented media and incubated for six days. Cells lysates were subjected to 
immunoblot analysis to examine levels of phospho-histone 3 as a measure of cell 
proliferation. (c) In serum-supplemented conditions, the levels of phospho-histone 3 
protein was not significantly different among cell lines. (d) In serum-free conditions, 
MT1-MMPst cells had significantly higher levels of phospho-histone 3 protein than MCF-
7 (p < 0.05) and ∆CD MT1-MMPst cells (p < 0.01), while the levels in MT2CD MT1-
MMP were not significantly different than in MCF-7 cells. (e, f) Densitometry analysis 
was performed on phospho-histone 3 protein levels in serum or serum-free culture 
conditions. Three independent samples of protein isolated from cell lines was analyzed 
and results are presented as mean relative optical density ± SEM, and were analyzed 
using one-way ANOVA; different letters signify differences at p < 0.05 according to 
Tukey’s B test. β-actin was used as a loading control.  
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A similar experimental design was used to assess viability and apoptosis in stable cell 
lines in serum-free stress. Cells were cultured in either serum-supplemented or serum-
free conditions for six days, and then viability and apoptosis measured using a fluorescent 
or luminescent substrate of relevant cell proteases, respectively. Relative to their 
corresponding levels in serum-supplemented conditions, MT1-MMPst cells showed a 
significant increase of ~19% in cell viability (p < 0.05) and showed significantly lowered 
caspase activity (p < 0.01) by ~11% than MCF-7 cells (Figure 11 a, b). ∆CD MT1-MMPst 
showed a significant ~40% decrease in viability as compared to control parental cell lines 
(p < 0.0001), while both MT2CD MT1-MMPst and ∆CD MT1-MMPst showed a ~16% 
significant increase in apoptosis (p < 0.001) in serum-free conditions than MCF-7 cells.  
Upon observing the changes in cell survival that occur in MT1-MMP stable cell lines 
upon serum starvation, the effect of serum starvation on cell morphology in 3D culture 
was examined. MCF-7, MT1-MMPst, MT2CD MT1-MMPst or ∆CD MT1-MMPst were 
seeded in Matrigel and incubated in serum-free media conditions for five days. On day 
one, the morphology of cell colonies was predominantly round, though MT1-MMPst, 
MT2CD MT1-MMPst or ∆CD MT1-MMPst cells showed more cellular protrusions than 
parental cells (Figure 12 a). By day five, colonies of all cell lines began showing a unique 
phenotype where cells within colonies lost cohesion, which was described as a 
“fractured” morphology distinct from round or protrusive cell colonies. This fracturing 
phenotype was observed ~14% less frequently in MT1-MMPst cells than MCF-7 cells, 
but was significantly more frequent (p < 0.01) by ~52% and ~57% respectively in 
MT2CD MT1-MMP and ∆CD MT1-MMPst cell colonies (Figure 12 b). No protrusions 
were observed on day five in any cell type in this serum-free condition. 
3.8 Changes to cell migration and survival are correlated to 
changes in AP-1 and NF-кB transcriptional activity  
To gain insight into the possible mechanisms of the observed increase in migratory 
capability and concomitant decrease in survivability in cells expressing MT1-MMP with 
altered cytoplasmic domains, a firefly luciferase gene reporter assay was conducted to 
assess the transcriptional activity of AP-1 and NF-кB transcription factors. Both AP-1 
and NF- кB have been implicated in changes in cell migration and survival  
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Figure 11. Mutation to the cytoplasmic domain of MT1-MMP impaired cell viability 
and increased apoptosis in MCF-7 cells following serum deprivation. 
MT1-MMPst, MT2CD MT1-MMPst, and ∆CD MT1-MMPst, or parental MCF-7 cells 
were seeded in either serum-free or serum-supplemented media and incubated for six 
days. A fluorescent viable cell enzyme substrate and a luminescent caspase substrate 
were added to cultures and the fluorescence and luminescence of cells measured as a 
metric of viability and apoptosis, respectively. Data are presented as viability or apoptosis 
levels in serum-free conditions relative to serum conditions for each cell line, and 
normalized to control MCF-7 cells. (a) After six days of incubation, MT1-MMPst cells 
were significantly more viable in serum-free stress conditions than parental cells (p < 
0.05), while ∆CD MT1-MMPst cells were significantly less viable than MCF-7 cells (p < 
0.0001). (b) After six days of incubation, MT1-MMPst cells had significantly less caspase 
activity than did MCF-7 cells in serum-free stress (p < 0.01), while both MT2CD MT1-
MMPst and ∆CD MT1-MMPst showed significantly more (p < 0.001) caspase activity 
than the parental cell line. The results of three independent experiments are presented as 
mean relative fluorescence or luminescence ± SEM, and were analyzed using one-way 
ANOVA; different letters signify differences at p < 0.05 according to Tukey’s B test. 
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Figure 12. Mutation to the cytoplasmic domain of MT1-MMP induced colony 
fracturing in 3D serum-free stress conditions. 
(a) Bright field microscopy images of MCF-7 and MT1-MMPst, MT2CD MT1-MMPst, 
and ∆CD MT1-MMPst cells in 3D culture upon serum starvation. Cells were seeded in 
Matrigel and the morphology of cell colonies within the matrix was observed at day one 
and day five. On day one, colonies were mostly round, though MT1-MMPst, MT2CD 
MT1-MMPst, and ∆CD MT1-MMPst cells showed more cellular protrusions than MCF-7 
cells. On day five, some cell colonies of MCF-7, MT2CD MT1-MMPst and ∆CD MT1-
MMPst developed a fractured phenotype where colonies lost internal cohesion. 
Representative morphologies are shown in inset images. (b) The morphology of cell 
colonies was assessed on days one and five as either round, protrusive or fractured. At 
day one, colonies of all cell lines were predominantly round, with no fractured colonies 
observed. MT1-MMPst, MT2CD MT1-MMPst, and ∆CD MT1-MMPst cell colonies 
showed more protrusions than MCF-7 cells. At day five, MT2CD MT1-MMPst and ∆CD 
MT1-MMPst cell colonies showed significantly more fracturing than MCF-7 cells (p < 
0.01). MT1-MMPst cell colonies remained mostly round, and had fewer fractured cell 
colonies than MCF-7 cells. The results of three biological replications are shown as mean 
proportion of total cell colonies ± SEM, and were analyzed using one-way ANOVA; 
different letters signify differences at p < 0.05 according to Tukey’s B test. 
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(Bakiri et al., 2015; Grandage et al., 2005). AP-1-regulated gene transcription was 
significantly increased by ~4.15-fold in MT1-MMPst (p < 0.0001), ~5-fold in MT2CD 
MT1-MMPst (p < 0.0001) and ~2.4-fold ∆CD MT1-MMPst cells (p < 0.05) compared to 
MCF-7 cells, although to different degrees (Figure 13 a). MT1-MMPst cells were the only 
cell lines to display significantly increased levels of NF-кB transcriptional activity, by 
~12.6-fold (p < 0.0001), as neither MT2CD MT1-MMPst and ∆CD MT1-MMPst cells 
showed significant differences in luminescence as compared to MCF-7 cells (Figure 13 
b). 
3.9 Substitution or deletion of the cytoplasmic domain of 
MT1-MMP impaired, but did not abolish, MT1-MMP-
mediated vascularization of artificial tumours embedded 
onto avian embryo CAM 
The increase in migration and development of cellular protrusions in cells imparted by 
MT1-MMP expression, as well as the increase in survivability metrics seen in vitro could 
both contribute to tumour growth. To assess the role that the cytoplasmic domain has in 
the overall tumourigenicity of MT1-MMP, artificial Matrigel tumours composed of 
ZsMCF-7, ZsMT1-MMPst, ZsMT2CD MT1-MMPst or Zs∆CD MT1-MMPst cells were 
embedded into a wound within the CAM vasculature of a nine day old chicken embryo 
and incubated for eight days. Following incubation the local vasculature surrounding the 
tumour site was observed and was determined to be either vascularized or non-
vascularized, depending on the presence or absence of capillaries above the embedded 
tumour (Figure 14 a). All control ZsMCF-7 cell tumours failed to grow beneath the CAM 
layer, the wound site failed to heal and there was no vascularization at the injection site 
(N = 13). Conversely, all but one (14/15) ZsMT1-MMPst cell tumours showed observable 
vascularization and growth beneath the CAM (Figure 14 b). Both ZsMT2CD MT1-
MMPst (9/16) and Zs∆CD MT1-MMPst (7/14) showed intermediate incidences of 
vascularized tumours between ZsMCF-7 cells and ZsMT1-MMPst cell tumours.  
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Figure 13. Altered transcriptional activity of AP-1 and NF-кB in cells expressing 
MT1-MMP was differentially dependent on the integrity of the cytoplasmic domain.  
MCF-7 and MT1-MMPst, MT2CD MT1-MMPst, and ∆CD MT1-MMPst cells were 
transfected with firefly luciferase under the regulation of AP-1 or NF-кB promotors. 
Cells were lysed and incubated with luciferin and the luminescence of lysate measured. 
All of MT1-MMPst (p < 0.0001), MT2CD MT1-MMPst (p < 0.0001), and ∆CD MT1-
MMPst (p < 0.05) showed significantly higher luminescence than MCF-7 cells following 
transfection with AP-1-luciferase. Only MT1-MMPst (p < 0.0001) cells showed 
significantly more luminescence than parental cells following transfection with NF-кB-
luciferase. The results of three biological replications are presented as mean 
luminescence ± SEM, and were analyzed using one-way ANOVA; different letters 
signify differences at p < 0.05 according to Tukey’s B test. 
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Figure 14. MCF-7 cell lines stably expressing cytoplasmic domain altered MT1-
MMP showed fewer instances of tumour vascularization in avian CAM. 
Stably expressing, ZsGreen-tagged cell lines ZsMT1-MMPst, ZsMT2CD MT1-MMPst, 
and Zs∆CD MT1-MMPst, as well as ZsMCF-7 cells were embedded in Matrigel and 
injected into a wound made to the vasculature of the CAM of a nine-day-old chicken 
embryo. Embryos were incubated for eight days, and the tumour site examined by bright 
field and fluorescence stereomicroscopy. The binary measurement of Tumour 
Vascularization was determined by identifying capillaries above and around tumours 
exhibiting growth beneath the CAM as present (A1, white arrows) or absent. The edge of 
the initial wound is also indicated (A2, white arrows) Scale bars = 1 mm (a) 
Representative bright field and fluorescence microscopy images of Matrigel tumours at 
day nine. Only ZsMT1-MMPst displayed healing and closure of the initial wound (A2, 
white arrows indicate scarring) as well as complete submersion and growth beneath the 
CAM, though some ZsMT2CD MT1-MMPst and Zs∆CD MT1-MMPst tumours did show 
partial growth beneath the CAM layer (middle, bottom panels). No ZsMCF-7 cell 
tumours exhibited growth beneath the CAM or vascularization at the tumour site. 
Vasculature was present at the tumour site in some tumours of ZsMT1-MMPst, 
ZsMT2CD MT1-MMPst, and Zs∆CD MT1-MMPst cells. (b) Multiple embryos were 
injected and the tumour sites were determined to be either vascularized or non-
vascularized depending on the presence or absence of vasculature near the tumour (N 
values shown above bars). While none of the ZsMCF-7 Matrigel tumours showed 
vascularization, all but one ZsMT1-MMPst tumours were vascularized. Both ZsMT2CD 
MT1-MMPst and Zs∆CD MT1-MMPst showed instances of vascularization in between 
those observed in ZsMCF-7 and ZsMT1-MMPst. A chi-squared test of independence was 
performed to examine the relationship between cell line and vascularization, and was 
found to be significant; χ2 (4, N = 58) = 24.48, p < 0.001. (c) Schematic illustrating the 
relative positions of the tumour, CAM and vasculature in chicken embryos. Shown are 
cross-sections perpendicular to the images shown in (a), along the depth of the CAM. In 
ZsMCF-7 cells, the tumour sits above the CAM and the wound was unhealed (i), while in 
ZsMT1-MMPst, the tumour is beneath the CAM with near complete wound closure (ii). 
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Both ZsMT2CD MT1-MMPst, and Zs∆CD MT1-MMPst cells show partial growth, where 
part of the tumour is beneath the vascularized CAM (iii).  
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Chapter 4  
4 Discussion 
This work aimed to examine the effects of cytoplasmic domain mutation on the migration 
and survival-promoting functions of MT1-MMP. Using MCF-7 breast cancer cells, which 
are deficient in MT1-MMP, multiple overexpression experiments were conducted using 
cDNAs encoding either full-length MT1-MMP, MT1-MMP possessing the substituted 
cytoplasmic domain of MT2-MMP, or MT1-MMP with no cytoplasmic domain. I 
hypothesized that swapping or deleting the cytoplasmic domain would disrupt the 
functions of MT1-MMP in cell migration and cell survival. However, the results 
presented here indicated that though the cytoplasmic domain is necessary for the 
promotion of cell survival, it was dispensable for MT1-MMP-mediated cell migration.   
4.1 The cytoplasmic domain of MT1-MMP regulates its 
activation  
Substitution or deletion to the cytoplasmic domain of MT1-MMP differently altered the 
protein activation profiles observed in transiently transfected MCF-7 cells (Figure 2 a). 
The lack of active MT1-MMP protein observed upon substitution of its cytoplasmic 
domain with that of MT2-MMP (MT2CD MT1-MMP) suggests that even with the high 
level of sequence similarity between these proteins at this domain, substitution interrupts 
the successful cleavage of MT1-MMP by its activator furin. This result seems at odds 
with reports that furin mediates the activation of other membrane-type MMPs possessing 
cytoplasmic domains, notably MT3-MMP (Kang et al., 2002), and that MT2-MMP 
contains a furin recognition sequence at its pro-domain (Butler et al, 1997). However, the 
presence of such a recognition site is not necessarily predictive of furin activity, and MT-
MMPs including MT1-MMP have been found to be activated through furin-independent 
mechanisms (Rozanov et al., 2001; Sato et al., 1999), primarily by MMPs. In addition, 
the possibility that the MT2-MMP cytoplasmic domain does not interact with furin is 
supported by the lack of identified adaptor proteins to mediate this interaction, while a 
putative adaptor protein has been described for the association of the MT1-MMP 
cytoplasmic domain with furin (Roghi et al., 2010). 
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The high levels of active MT1-MMP protein observed in cells following transfection with 
∆CD MT1-MMP prompted further investigation, as it was expected that cytoplasmic 
domain deletion would have similar negative effects on protein activation as domain 
substitution. Indeed, the activation of MT1-MMP protein lacking the cytoplasmic domain 
appeared to be mediated not by furin, but through an MMP-dependent mechanism 
(Figure 2 c). This MMP-mediated activation did not occur in cells transfected with FL 
MT1-MMP, suggesting that this activation occurs via a non-canonical process in these 
transfection and culture conditions. It is proposed here that this activation of MT1-MMP 
protein without the cytoplasmic domain occurred by auto-activation in trans through 
cleavage of the pro-peptide at the cell surface. Two observations support this: the high 
levels of pro-MT1-MMP generated following ∆CD MT1-MMP transfection, as well as 
the cell surface localization of the resultant protein. The distribution of cell surface MT1-
MMP lacking the cytoplasmic domain appeared as dense clusters at the cell surface, and 
the high levels of MT1-MMP protein detected by western blot analysis suggest that these 
clusters are highly concentrated in MT1-MMP protein. As sequences in the cytoplasmic 
domain promote the internalization of this protein (Uekita et al., 2001; Williams & 
Coppolino, 2011), these high levels appear to be a result of a deficiency in protein 
internalization and degradation. This accumulation of many, densely packed MT1-MMP 
monomers that cannot be regulated by internalization may allow for low, atypical 
proteolytic activity of pro-MT1-MMP to cleave and activate nearby MT1-MMPs, which 
would spread within protein clusters. This hypothesis is plausible given multiple 
observations regarding MT1-MMP activation. MT1-MMP is known to experience 
autocatalysis in trans, although at the catalytic domain rather than pro-domain, as it 
generates the 44 kDa autocatalytic degradation product (Cho et al., 2008; Osenkowski, 
Toth, & Fridman, 2004). There is also evidence that MT1-MMP may undergo a two-step 
activation process, including an autocatalysis step (Strongin, 2010). In addition, MMP 
family members have been shown capable of cleaving and activating other MMPs, as 
observed during MT1-MMP activating MMP-2 (Itoh et al. 2001) or MMP-2 activation 
MMP-9 (Fridman et al., 1995).  
 
In MDA-MB-231 cells, the activation profiles of cytoplasmic-domain altered MT1-MMP 
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proteins was mostly consistent with those observed in MCF-7 cells. Notable differences 
were the lack of a 44 kDa degradation product following FL MT1-MMP transfection, and 
lack of an active MT1-MMP protein band following ∆CD MT1-MMP transfection. Both 
of these differences can be explained by the inhibitory activity of TIMP-2, which is 
expressed at much higher levels in MD-AMB-231 cells than MCF-7 (Figueira et al., 
2009). As both the autocatalysis and posited auto-activation of MT1-MMP are mediated 
by MT1-MMP proteolysis, the inhibition of MT1-MMP upon TIMP-2 exposure explains 
the absence of these protein forms.  
4.2 Cytoplasmic domain-dependent cell surface localization 
of MT1-MMP determines its ability to cleave substrate 
MCF-7 cells transfected with FL MT1-MMP showed a cell surface distribution of MT1-
MMP protein that is consistent with patterns observed in other studies examining 
unstimulated, transfected cells (Remacle, Murphy, & Roghi, 2003; Wang et al., 2004). 
FL MT1-MMP appeared uniform across the entire cell surface, in a pattern congruent 
with the actin cytoskeleton (Figure 3). In contrast, neither MT2CD MT1-MMP nor ∆CD 
MT1-MMP transfection resulted in this surface distribution, as these altered MT1-MMP 
proteins failed to localize along the cell edge or to the distal end of protrusive actin cell 
structures. The filamentous cell surface pattern of MT2CD MT1-MMP was consistently 
observed, but an explanation for such a pattern cannot currently be suggested, as MT2-
MMP is not as rigorously studied as MT1-MMP. Should the distribution of MT2-MMP 
be similar to that of MT2CD MT1-MMP, it would suggest a consistent, prominent role of 
the cytoplasmic domain for the localization of MT-MMPs. The clustering of MT1-MMP 
protein upon cytoplasmic domain deletion may be a result of non-targeted insertion and 
maintenance at the cell membrane, or aberrant binding of MT1-MMP proteins via the 
hemopexin domain arising from a lack of regulatory internalization signals normally 
provided by the cytoplasmic domain.  
While cells transfected with either FL MT1-MMP or ∆CD MT1-MMP showed levels of 
active MT1-MMP, only transfection with FL MT1-MMP resulted in the activation of 
pro-MMP-2 and the degradation of gelatin. This suggests that while active MT1-MMP is 
required for this process, its cell surface localization is an important factor for proteolysis 
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to occur. As MT1-MMP proteins dimerize during pro-MMP-2 activation, a cell surface 
distribution pattern that does not permit appropriate dimerization may impact this activity 
and other functions. Indeed, the cytoplasmic domain mediates disulphide bonding of 
MT1-MMP monomers during MMP-2 activation, and its deletion abrogates this 
dimerization (Lehti et al., 2002). This suggests a requirement of both the proteolytic 
ability to cleave MMP substrates and a permissive spatial distribution required of this 
interaction.   
However, some reports have shown MT1-MMP lacking its cytoplasmic domain is 
capable of activating pro-MMP-2 in zymography analysis (Itoh et al. 2008; Li et al. 
2008). As these reports show that ∆CD proteins appear in an active form by western blot, 
this observation is plausible. The inconsistency of previous studies with the data 
presented here (Figure 4) may be due to the use of different cell lines, which include 
COS7, COS-1, and HT1080, or differences in expression vectors used, which could result 
in lower proteins levels that are more permissive to proper protein interactions. 
 
The degradation of gelatin is accomplished primarily by the activity of MMP-2 (Toth & 
Fridman, 2013). Therefore, the presence of active MMP-2 as shown by zymography is 
consistent with only FL MT1-MMP-transfected cells being capable of gelatin degradation 
(Figures 4, 5). However, a further observation regarding MT1-MMP cytoplasmic domain 
mutation in cells seeded upon gelatin was the appearance of MT1-MMP that co-localized 
with actin puncta. While these punctate actin structures were not positively identified as 
invadopodia, their morphology is consistent with these basal actin protrusions. To 
confirm the formation of invadopodia additional protein markers are required, such as 
cortactin or Tsk5 (Artym, 2006; Clark et al., 2007; Leong et al., 2014). However, if these 
invadopodia-like structures are representative of true invadopodia, this suggests that the 
cytoplasmic domain is dispensable during the recruitment of MT1-MMP to invadopodia. 
This contrasts with other observations made in this study that show MT1-MMP protein is 
improperly localized at the cell surface (Figure 3), and may mean that MT1-MMP 
recruitment to invadopodia can occur passively through the trafficking of other proteins, 
such as integrins (Artym, 2006). As MT1-MMP has been shown to bind integrins 
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(Gálvez et al., 2002) during their translocation, MT1-MMP may be recruited with 
integrins through binding at the extracellular hemopexin-like domain of MT1-MMP.   
4.3 The cytoplasmic domain of MT1-MMP is not required 
for cell migration and negatively regulates the 
development of invasive cell protrusions 
In both transiently transfected and stably expressing MCF-7 cell lines, cytoplasmic 
domain substitution (MT2CD MT1-MMP) or deletion (∆CD MT1-MMP) within MT1-
MMP increased the migration of cells relative to control conditions (Figures 6, 8). This 
was observed across multiple migration assays, as cells containing these altered forms of 
MT1-MMP migrated further into a wound space, and more often through the small pores 
of transwell chambers than did parental MCF-7 cells. As these mutants of MT1-MMP 
show little proteolytic activity, which has frequently been implicated in MT1-MMP-
mediated cell migration, the observed migration ability is likely due to non-proteolytic 
mechanisms. 
A number of observations regarding the migration-promoting activity of MT1-MMP 
directly refer to mechanisms that do not depend on proteolysis. These include sequences 
in the catalytic domain which do not impact enzymatic activity (Woskowicz et al., 2013), 
and blades I and IV of the hemopexin domain, which allow for homo- or heterodimers of 
MT1-MMP to form and result in ERK activation (Zarrabi et al., 2011). Indeed, some 
studies show that upon cytoplasmic domain deletion the invasive capability of cells is 
maintained (Li et al., 2008). In addition, the inhibition of all MMP proteolytic activity in 
invasive human breast cancer cell lines has been shown to result in the promotion of an 
amoeboid migration phenotype which relies on changes in cell morphology without 
accompanying ECM degradation (Wolf et al., 2003). Indeed, a non-proteolytic 
mechanism of increased cell migration involving cytoskeletal arrangements is also 
supported by the increased levels of cell invasion observed in this study (Figure 6). As 
the Matrigel barrier employed in the transwell invasion assays used was diluted, the 
corresponding increase in size between ECM proteins within it may have been permissive 
to an amoeboid method of cell invasion, rather than one dependent on proteolysis, and 
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may explain why cells transfected with MT2CD MT1-MMP and ∆CD MT1-MMP 
invaded more than FL MT1-MMP or GFP. 
This sort of distinct change in cell morphology was observed in this study upon 
cytoplasmic domain mutation to MT1-MMP, as cells developed protrusive cell 
extensions in MT1-MMP stable cell lines cultured in a 3D Matrigel matrix (Figure 9). 
Using immunofluorescence, it was determined that these protrusions were rich in F-actin, 
suggesting that they may be of similar form and function as filopodia or invadopodia and 
could promote the migration or invasion of cells. Uncharacterized invasive protrusions 
have previously been reported to form in MT1-MMP-expressing breast cancer cells 
cultured in 3D matrices. The growth of these actin-rich formations was regulated by the 
actin nucleation-promoting protein N-WASP (Neural Wiskott-Aldrich syndrome protein), 
which was shown to have a specific role in both the trafficking of MT1-MMP to these 
structures, and tethering and stabilizing the protease at this location via the MT1-MMP 
cytoplasmic domain (Yu et al., 2012). It is then plausible that in MT2CD MT1-MMPst 
and ∆CD MT1-MMPst cells, which possess mutated MT1-MMP cytoplasmic domains, 
this N-WASP-mediated stabilization does not occur, and the development and growth of 
these protrusions lack an organized resolution provided by MT1-MMP stability. This is 
well-supported by the observation that MT2CD MT1-MMPst and ∆CD MT1-MMPst cells 
showed significantly more cellular protrusions at a much earlier time than MT1-MMPst, 
and cells remained more protrusive for the duration of experiments (Figure 9).  
Assessing the protrusive morphology of breast cancer cells in 3D culture has been widely 
utilized as it strongly correlates with invasive and migratory ability (Kenny et al., 2007; 
Lee et al., 2010). In particular, “stellate” cell colonies arise from invasive cell types, such 
as MD-AMB-231 breast cancer cells, and are characterized by long cellular extensions. 
In contrast, low-invasive cell lines such as MCF-7 remain predominantly round. The 
protrusions observed in MT1-MMPst, MT2CD MT1-MMPst and ∆CD MT1-MMPst cells 
may be indicative of an acquired invasiveness, as their protrusive morphology aligns with 
that of stellate colonies.  
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The results of these migration assays and observations made in 3D culture suggest that 
MT1-MMP may be capable of promoting cell migration and invasion independent of 
proteolysis by influencing the organization of the actin cytoskeleton, priming cells to 
adopt features such as cell protrusions that facilitate migration. Rather than impede this 
mechanism, the cytoplasmic domain may be a negative regulator in the non-proteolytic 
mechanism of MT1-MMP-induced cell migration.  
Notably, all of the described migration-promoting mechanisms of MT1-MMP are diverse 
and lack unification. This is in contrast to the extensive and specific mechanisms which 
exist to describe MT1-MMP in the activation of pro-MMP-2 (Itoh et al., 2001), the 
switch to glycolytic cell metabolism (Sakamoto & Seiki, 2010), or degradation at 
invadopodia (Artym, 2006). In addition, and consistent with the breadth of migration-
promoting mechanisms ascribed to MT1-MMP, it should be noted that while the stable 
expression of wild-type MT1-MMP resulted in increased cell migration, expression of the 
same cDNA following transient transfection was incapable of changing cell migration. 
This difference, which did not occur with the cytoplasmic domain-altered forms of MT1-
MMP, is not easily explained. However, the work presented here regarding cytoplasmic 
domain mutation resulting in increased cell migration adds a layer of complexity to this 
already poorly understood function of MT1-MMP, and suggests that the traditional view 
of induction via proteolytic cleavage is far from a complete model. 
4.4 The cytoplasmic domain of MT1-MMP is indispensable 
for its ability to promote cell survival and protect cells 
from apoptosis 
MT1-MMPst, which expressed wild-type MT1-MMP, showed significantly more 
proliferation and increased viability than MCF-7 cells in serum-free stress conditions, 
while MT2CD MT1-MMPst and ∆CD MT1-MMPst showed less proliferation and more 
apoptosis than MT1-MMPst (Figures 10, 11). Multiple mechanisms exist by which MT1-
MMP could induce such a cell survival response. The first of these involves the ability of 
MT1-MMP to induce the Warburg Effect, a shift in cell metabolism to favour glycolysis. 
During maturation in the Golgi, MT1-MMP binds to the trafficking protein Mint3 
thereby promoting the local recruitment of Factor Inhibiting HIF-1α. This sequestration 
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relieves the transcription factor HIF-1α of inhibition, allowing it to induce the hypoxic 
response through the activation of glycolytic gene expression. Observed in both 
lymphocytes and breast cancer cells this increase in glycolysis directly increases cell 
survival and does not depend on oxygen levels. Importantly, the binding of Mint3 to 
MT1-MMP depends on its cytoplasmic domain, explaining the observation that only 
MT1-MMPst cells showed increased cell survival (Sakamoto et al., 2011; Sakamoto & 
Seiki, 2010). In addition, MT1-MMP protects cells from apoptosis by activating the Akt 
pathway. Akt is a serine/threonine kinase and a central mediator of the PI3-K signaling 
pathway, which affects apoptosis, cell survival and cell growth (Grandage et al., 2005). 
Specifically, TIMP-2 binding to MT1-MMP caused the activation of Akt, which reduced 
breast cancer cell apoptosis induced by serum starvation. MCF-7 cells express low but 
not negligible levels of TIMP-2, and thus an Akt-dependent mechanism is possible in the 
explaining the observed low apoptosis in MT1-MMPst. In addition, this Akt activation 
was dependent on the activation of the cytoplasmic membrane-associated protein Ras. 
(Valacca et al., 2015). Therefore, both Warburg effect induction and the activation of Akt 
depend on distinct protein interactions. This may suggest that the loss of cell survival 
observed in MT2CD MT1-MMPst and ∆CD MT1-MMPst may be due to improper cell 
localization which does not permit proper protein interactions. 
While the absence of signal transduction-capable MT1-MMP may explain a loss of 
protection from apoptosis, MT2CD MT1-MMPst and ∆CD MT1-MMPst showed more 
apoptosis than parental cells, suggesting that these mutations are actually cytotoxic. A 
proposed reason for this toxicity may relate to the morphology of these cells as observed 
in 3D cell culture. The extensive actin-rich protrusions observed in these cells is 
suggestive of a dysregulation in actin polymerization dynamics. It has been shown that 
cytoskeletal deformation caused by actin instability can result in apoptosis, and 
specifically excessive F-actin accumulation has been shown to instigate apoptotic cell 
death (Gourlay & Ayscough, 2005; Kulms et al, 2002). The unregulated protrusive 
growth in MT2CD MT1-MMPst and ∆CD MT1-MMPst may bring about apoptosis due to 
these numerous actin structures. 
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Most of the results collected across multiple cell behaviour assays showed a similar 
pattern whether cells were expressing MT2CD MT1-MMP or ∆CD MT1-MMP, a trend 
which was expected due to both constructs experiencing cytoplasmic domain mutation. 
However, the stable cell lines MT2CD MT1-MMPst and ∆CD MT1-MMPst showed 
differences in cell viability, whereby the former displayed no difference in viability 
compared to parental MCF-7 cells and the latter showed significantly lower viability. To 
account for this difference in viability observed, the catalytic ability of each protein 
product must be considered. Notably, the other difference observed between the 
behaviour of these two constructs was in MT1-MMP protein activation. MT2CD MT1-
MMP showed very low levels of active MT1-MMP protein, while cytoplasmic domain 
deletion results in a protein product that showed an active form (Figure 2 a). Importantly, 
the ∆CD MT1-MMP is presumed to lack regulation of its proteolytic activity through 
internalization. This persistent catalytic activity at the cell surface may result in the 
cleavage of cell surface receptors necessary for cell survival, or trigger other apoptotic 
events.     
The mechanisms of these anti-apoptotic and pro-migratory effects of MT1-MMP may be 
related to changes in transcription in each stable cell line. Indeed, it was shown that MT1-
MMP influenced the transcriptional activity of other genes in a manner that depended on 
the integrity of its cytoplasmic domain. Observed in this study were changes in the 
transcription activity of nuclear factor kB (NF-кB) and adaptor protein-1 (AP-1).  
NF-кB belongs to a family of related transcription factors that were characterized during 
immune cell development, where they play an essential role. However, it also regulates 
diverse functions including cell survival, notably protecting cells from apoptosis by 
mechanisms such as the inhibition of PTEN (Grandage et al., 2005; Vasudevan, 
Gurumurthy, & Rangnekar, 2004). Importantly, NF-кB is activated through the Akt 
pathway, which can be induced by MT1-MMP (Valacca et al., 2015). As only MT1-
MMPst cells showed increased levels of NF-кB activity, and were also the only cells to 
show reduced levels of apoptosis, the notion that MT1-MMP mediates apoptosis evasion 
through Akt/NF-кB is reasonable. This also suggests that the stimulation of NF-кB 
depends on the cytoplasmic domain of MT1-MMP. However, as NF-кB promotors are 
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present upstream of MT1-MMP, it is possible that the increased transcriptional activity is 
a feedback loop resulting from increased MT1-MMP expression.   
Also examined was the activity of AP-1, a group of transcription factors which form from 
the dimerization of Fos and Jun family members, and regulate diverse cell functions 
including cell growth and cell death (Bakiri et al., 2015). AP-1 transcription factors are 
also implicated in epithelial-to-mesenchymal transitions in human breast cancer, through 
increasing cell migration and invasion (Bakiri et al., 2015). AP-1 transcriptional activity 
was observed to be elevated in all of MT1-MMPst, MT2CD MT1-MMPst and ∆CD MT1-
MMPst cells compared to parental MCF-7 (Figure 13). Though the cause of the increase 
in AP-1 transcription activity upon MT1-MMP expression or activity are not known, its 
activity is consistent with the increase in cell motility observed across all MT1-MMPst, 
MT2CD MT1-MMPst and ∆CD MT1-MMPst cell lines, and suggests that the cytoplasmic 
domain is not needed for MT1-MMP-mediated AP-1 transcriptional activity. In addition, 
while no evidence exists that MT1-MMP directly increased AP-1 transcription, AP-1 
binding sites are located in promotor regions of MMPs -1, -3, -7, -9, -10, -12 and -13, and 
AP-1 increases the transcription of MMP-2 (Bergman et al., 2003). It is absent in the 
promotor region of MT1-MMP. Therefore, a feedback system may be in place whereby 
migratory cells, partially induced by the function of MT1-MMP, organize transcriptional 
machinery to further increase MMP gene expression.  
4.5 MT1-MMP-mediated cell migration and cell survival 
both contribute to the development of tumourigenic 
phenotypes ex vivo and in vivo.  
Having observed changes to cell migration and cell survival, assays were performed 
which examined the concurrent activity of these cellular processes ex vivo and in vivo. 
The ex vivo 3D culture technique discussed earlier used incubation media supplemented 
with serum, which resulted in a protrusive, invasive cell morphology (Figure 9). This 3D 
culture model was adapted, and cultures were serum starved to introduce a stress 
condition which contrasted the established migration-promoting effects of embedment in 
Matrigel. While cellular protrusions were present after one day of incubation in MT1-
MMPst, MT2CD MT1-MMPst and ∆CD MT1-MMPst cells, this phenotype was 
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completely absent in all cell lines after five days of serum starvation (Figure 12). This is 
in contrast to the dramatic protrusions observed on day five in serum-supplemented 
conditions, and may be a result of cells shifting from a migratory phenotype to one 
focused on cell survival. Indeed, aside from round cell colonies, the morphological 
feature observed in serum-free 3D culture was a fracturing of cell colonies as individual 
cells appear to lose cohesion to each other. This occurred less in MT1-MMPst cells and 
more frequently in MT2CD MT1-MMPst and ∆CD MT1-MMPst cells compared to MCF-
7. This fracturing morphology of cells upon the loss of colony cohesion appears to be 
consistent with cell death, likely by apoptosis. Interestingly, the pattern of high 
proportion of fracturing cell colonies in MT2CD MT1-MMPst and ∆CD MT1-MMPst 
cells was strongly representative of the one observed for apoptosis, as both of these cell 
lines had increased caspase activity when serum-starved (Figure 11). This suggests that 
MT2CD MT1-MMPst and ∆CD MT1-MMPst cells, despite showing high migratory 
capability, lack longitudinal invasive potential as they are unable to survive in stress 
conditions.  
These 3D serum-free culture results (Figure 12) were corroborated in vivo with the use of 
Matrigel tumours injected into the CAM of avian embryos (Figure 14). The CAM 
environment provides a balance of pro-migratory signals, as cells are induced to migrate 
along ECM proteins beneath and within the CAM, while also being faced with as a stress 
environment created by being encased in a healing chick tissue that initially lacked 
organized blood flow, as well as recognition by the developing avian immune system 
(Ribatti, 2010). Thus, CAM insertion is an excellent model to examine the contributions 
of cell migration and cell survival as they relate to the ability of a tumour to thrive in 
vivo, and it is frequently used to examine tumour growth, metastasis and intravasation 
(Deryugina & Quigley, 2009). Upon incubation in the CAM, MT1-MMPst cell tumours 
grew beneath the CAM layer, which healed well above the tumour, and became 
surrounded by vasculature, evidence that these cells were highly tumourigenic (Figure 
14). This may be a result of the increased levels of migration and survival in stress 
conditions observed in MT1-MMPst cells. In contrast, MCF-7 tumours did not move 
beneath the CAM and there was little healing of the wound around them, and no MCF-7 
cell tumours showed vascularization at the wound site. Interestingly, both MT2CD MT1-
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MMPst and ∆CD MT1-MMPst cell tumours showed an intermediate invasive phenotype, 
as some of the tumour has expanded beneath the CAM and became vascularized, while 
half of the tumour remained exposed and the wound site was not healed. In addition, 
incidences of vascularization occurred approximately 50% as frequently in MT2CD 
MT1-MMPst and ∆CD MT1-MMPst cell tumours as with MT1-MMPst. While a 
simplification, this pattern illustrates a relationship between cell migration and cell 
survival as they contribute to tumourigenicity: where MT1-MMPst cells show increased 
levels of both of these aspects, MT2CD MT1-MMPst and ∆CD MT1-MMPst cells lack the 
ability to increase cell survival, and therefore show decreased, but not abolished, levels of 
tumour vascularization. Thus mutations within the cytoplasmic domain of MT1-MMP 
that promote increased cell motility and decreased cell survival indicates that this domain 
has a physiological effect on breast cancer cells.   
4.6 A role for the cytoplasmic domain as a regulator of 
protein binding and localization 
Collectively, the results presented here suggest that the MT1-MMP cytoplasmic domain 
serves to mediate protein activation and localization, two aspects that have wide-reaching 
influence on the function of MT1-MMP and consequently cell behaviour. The 
cytoplasmic domain is necessary for the presumed furin-mediated activation of MT1-
MMP protein, and for its peripheral localization at the cell surface. Disturbances to this 
cortical localization, which may coincide with an inability to bind N-WASP and stabilize 
the growth of extensive membrane protrusions, may contribute to increased cell motility. 
Indeed, this work suggests that non-proteolytic mechanisms of MT1-MMP-mediated cell 
migration exist due to cytoskeletal rearrangements, and that the cytoplasmic domain may 
be a negative regulator of this phenotype. Cytoplasmic domain mutation resulted in an 
inability to promote cell survival, which may be due to a lack of specific binding of 
proteins to the cytoplasmic domain or dysregulation of cell surface localization to areas 
lacking in necessary partner proteins. Dysregulation of the cytoskeleton upon 
cytoplasmic domain mutation may also contribute to apoptosis, while the negative 
regulation of proteolysis provided by cytoplasmic domain-mediated MT1-MMP 
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internalization may protect cells from toxicity induced by extended MT1-MMP 
proteolysis.  
This work also challenges the sweeping claims regarding the role of the cytoplasmic 
domain in MT1-MMP function, particularly in the mediation of Akt and ERK signaling. 
While it may be true that these processes depend on the cytoplasmic domain, it is likely 
that this dependence is indirect, perhaps as a consequence of mislocalization. Indeed, 
there may exist a “domino effect” of altered protein behaviour that occurs upon 
cytoplasmic domain mutation. It is shown here that the cytoplasmic domain is required 
for MT1-MMP activation by furin and protein localization, but any downstream affects, 
such as that on cell signaling, may be more caused by mislocalization rather than a direct 
result of cytoplasmic domain mutation. Nonetheless, the dysregulation of cell behaviour 
observed upon cytoplasmic domain mutation to MT1-MMP illustrates the diverse and 
profound functions of MT1-MMP.  
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Figure 15. A model of the regulation of protein function and cell behaviour by the 
cytoplasmic domain of MT1-MMP. 
Model outlining the proposed changes to MT1-MMP protein function upon disruption to 
the cytoplasmic domain. This model developed from data collected from this work, and 
presumptive functions described in the MT1-MMP literature. Overall, the functions of 
MT1-MMP promote a cell phenotype capable of surviving stress and migrating through 
tissues, promoting tumourigenicity (Figure 14). (a) During protein maturation in the 
Golgi, the cytoplasmic domain is required for furin-mediated protein activation. 
Immunoblot analysis of cells transfected with MT2-MMP cytoplasmic domain 
substitution and domain deletion constructs interrupted this activation in two cell lines 
(Figure 2 a - d). (b) High levels of ∆CD MT1-MMP protein as compared to FL MT1-
MMP and MT2CD MT1-MMP may be due to accumulation at the cell surface as a result 
of disrupted internalization (Figure 2 a, e). In addition, while FL MT1-MMP localized 
along the cell periphery, MT2CD and ∆CD MT1-MMP showed diffuse and clustered 
patterns, respectively (Figure 3). Only FL MT1-MMP localized at the cell surface in a 
pattern permissive to pro-MMP-2 activation (Figure 4), a distribution pattern altered upon 
cytoplasmic domain alteration. High levels of ∆CD MT1-MMP may cluster and auto-
activate, resulting in low levels of unregulated catalysis at the cell surface (Figure 2 c). 
(c) The cytoplasmic domain was dispensable for the recruitment of MT1-MMP to actin 
puncta in stimulated cells grown on gelatin substrate (Figure 5). This suggests other 
proteins may mediate its localization to this site through binding of extracellular domain. 
Only FL MT1-MMP resulted in degradation at this site, partially due to its successful 
activation of MMP-2. (d) The stable expression of MT2CD and ∆CD MT1-MMP caused 
extensive actin protrusions in cells (Figure 9), as well as increased rates of migration 
comparable to stable expression of FL MT1-MMP (Figure 8). The development of 
protrusions instigated by MT1-MMP may be negatively regulated by its cytoplasmic 
domain, as FL MT1-MMP still caused these structures to form albeit to a lesser degree. 
This regulation may occur due to the activity of N-WASP docking MT1-MMP to actin. 
The cytoskeletal dysregulation as evidenced by these extensive protrusions may also 
activate apoptosis in cells expressing MT2CD and ∆CD MT1-MMP (Figure 11). (e) Only 
MT1-MMP with its appropriate cytoplasmic domain showed an ability to enhance cell 
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viability and protect cells from apoptosis (Figure 11), presumably through the activation 
of Akt. This could occur directly through the cytoplasmic domain, or through interactions 
with binding partners at appropriate cellular locations. MT2CD MT1-MMP did not affect 
cell viability, while ∆CD MT1-MMP decreased cell viability, perhaps a result of 
unregulated cell surface receptor cleavage. (f) The activity of transcription factors AP-1 
was increased in cells regardless of the integrity of the cytoplasmic domain of the 
expressed MT1-MMP, while increased NF-кB activity only occurred in cells expressing 
full-length unaltered MT1-MMP (Figure 13). The resultant gene transcription from AP-1 
activity may increase cell migration, while increased NF-кB may protect cells from 
apoptosis. Presumably, as a result of the MT1-MMP cytoplasmic domain recruiting FIH, 
the HIF-1α hypoxic response is induced to enhance cell survival.
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Chapter 5  
5 Conclusion 
MT1-MMP is a multifunctional protease strongly implicated in the instigation and 
progression of cancer by promoting cell motility and survival. As shown here, these 
functions are differentially regulated by the cytoplasmic domain. Mutation of the 
cytoplasmic domain by substitution or deletion interrupted the furin-mediated activation 
of MT1-MMP and altered its cell surface distribution. MT1-MMP was capable of 
promoting cell motility regardless of the status of its cytoplasmic domain. In contrast, the 
survival-promoting functions of MT1-MMP through increased cell proliferation and 
decreased apoptosis specifically depended on the cytoplasmic domain. It was 
hypothesized that all MT1-MMP functions would depend on the cytoplasmic domain, 
and that the expression of cytoplasmic-domain altered forms would impair cell migration 
and cell survival. However, it appears that these two aspects of MT1-MMP functionality 
are independent with respect to the role of the cytoplasmic domain. Both the pro-
migratory and pro-survival functions of MT1-MMP contribute to cell tumourigenicity, as 
cytoplasmic domain alteration impaired tumour vascularization. However, tumour growth 
was not abolished, suggesting that cell migration is an important component to this 
phenotype. By expanding the understanding of both the cytoplasmic domain of MT1-
MMP, as well as how multiple functions of MT1-MMP contribute to cell invasiveness, 
this work provides a comprehensive model regarding the roles of MT1-MMP in invasive 
cells. 
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